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Potential roles of peroxidases in Caenorhabditis elegans innate immunity 
George Ross Tiller, B.S. 
Supervisory Professor, Danielle A. Garsin, Ph.D. 
The production of ROS (reactive oxygen species) in response to pathogen detection 
is a rapid, nonspecific response that is evolutionarily conserved from nematodes to 
humans. ROS serve as direct and indirect effectors of innate and adaptive immunity. In 
Caenorhabditis elegans, a ROS burst is observed during infection and is mediated by the 
dual oxidase BLI-3, which produces H2O2. RNAi (RNA interference) to reduce the amount 
of BLI-3 results in a significant increase in susceptibility to pathogens, suggesting BLI-3 has 
a role in the immune response. However, H2O2 by itself is not a potent antimicrobial and in 
other systems is converted to a more potent oxidant by an affiliated peroxidase. During my 
work, I have characterized a group of previously unstudied peroxidases in C. elegans and 
determined their involvement in the host immune response to Enterococcus faecalis. In 
particular, I focused on SKPO-1 (ShkT-containing peroxidase) and how it contributes to the 
host immune response with respect to BLI-3. 
By RNAi and skpo-1 mutant analysis, I determined that SKPO-1 is involved in the 
host immune response during E. faecalis infection. By tissue-specific RNAi, I determined 
that SKPO-1 is functionally active in the hypodermis and required for wild type resistance to 
infection. Additionally, by immunohistochemistry, I observed that SKPO-1 is only expressed 
in the hypodermis and that its protein levels do not change in response to E. faecalis. In 
support of SKPO-1 acting as a peroxidase, I observed a significant increase in H2O2 levels 
when expression of the gene was reduced by RNAi.  The increased H2O2 was observed 
only during infection and was BLI-3-dependent. Thus, I have characterized a likely BLI-
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3/SKPO-1 system, potentially similar to the oxidative burst systems present in higher 
eukaryotes.  
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Introduction and Background 
Caenorhabditis elegans as a model for infectious diseases 
 In 1999, the Ausubel laboratory developed Caenorhabditis elegans as a model for 
medically relevant infectious agents in mammals. Using Pseudomonas aeruginosa, they 
demonstrated that the pathogen utilized some of the same virulence factors to cause 
infection in simple and complex metazoan hosts, i.e. nematodes and mice (TAN et al. 
1999a; TAN et al. 1999b). Since then, C. elegans as an infectious disease model has been 
used to investigate both sides of host-pathogen interactions by elucidating how bacterial 
and fungal virulence factors cause infection in the host. Some of the pathogen models 
studied in C. elegans are Staphylococcus aureus, Enterococcus faecalis, Yersinia pestis, 
Salmonella enterica, Drechmeria coniospora and Cryptococcus neoformans  (GARSIN et al. 
2001; MYLONAKIS et al. 2002; PUJOL et al. 2008; STYER et al. 2005; TENOR et al. 2004). 
How the host defends against different pathogen insults is very important. By using C. 
elegans it is possible to genetically dissect host defense mechanisms that may be 
extremely difficult or even impossible to address in mammals due to increased complexity 
in their innate immune responses.  
In C. elegans, the β-catenin human ortholog, bar-1, and a downstream homeobox 
transcription factor (HOX) known as EGL-5 (egg-laying defective) contribute to the host’s 
resistance to S. aureus in the intestinal epithelia (IRAZOQUI et al. 2008). BAR-1 and EGL-5-
like proteins are evolutionarily conserved in humans and play an important role in intestinal 
immunity (IRAZOQUI et al. 2008). In humans, ɑ-defensins are modulated through the β-
catenin pathway and these antimicrobial peptides are important in intestinal epithelia 
defense (ANDREU et al. 2005), (VAN ES et al. 2005). Like in C. elegans, the human HOX 
genes cdx1/2 and hoxa9 are transcriptional targets of the β-catenin pathway and these 
homeobox transcription factors regulate expression of antimicrobial factors in the human 
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intestinal epithelia thus contributing to the innate immune response (ANDREU et al. 2005), 
(VAN ES et al. 2005), (IRAZOQUI et al. 2008). Thus, the β-catenin pathway and HOX 
transcription factors maintain their role in modulating host intestinal defense from C. 
elegans to humans. 
Another example of where humans increased our understanding of human innate 
immunity came from the discovery of the Toll signaling pathway’s involvement in Drosophila 
melanogaster innate immunity (LEMAITRE et al. 1996). These TLR (Toll-like receptor)-
mediated innate immune responses have been observed in vertebrates, including humans, 
which demonstrates TLRs are ancient, and evolutionarily conserved (COUILLAULT et al. 
2004), (PUJOL et al. 2001), (TENOR et al. 2004); reviewed by (IRAZOQUI et al. 2010b). Like 
vertebrates, C. elegans has a Toll-pathway consisting of TOL-1 (Toll-like receptor), PIK-1 
(Pell/IRAK kinase), TRF-1 (TNFR-associated factor), and IκB (inhibitor of NF-κB) (PUJOL et 
al. 2001). However, C. elegans lacks a NF-κB transcription factor homolog that canonical 
TLR pathways activate to mediate an innate immune response (PUJOL et al. 2001). In 
contrast to the TLR pathways present in vertebrates, the C. elegans Toll pathway is crucial 
for nematode development, but has a very minor role in mediating host resistance to 
pathogens, as tol-1 mutants are only hypersusceptible to Salmonella enterica  (TENOR et al. 
2004), (TENOR and ABALLAY 2008). Thus, the importance of TLRs recognizing pathogen 
associated molecular patterns (PAMPs) resulting in host immune response modulation 
appears to have evolved after the last common ancestor shared by C. elegans and 
humans.  
With respect to mammalian immunity, it is currently unknown if insulin-like growth 
factor (IGF) signaling directly affects immunity. However, the IGF/abnormal Dauer formation 
(IGF/DAF-2) pathway has been well-studied in C. elegans due to its involvement in innate 
immunity, various environmental stresses, reproduction, and metabolism (EVANS et al. 
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2008), (WOLKOW et al. 2000). DAF-2 negatively regulates DAF-16 through phosphorylation; 
however, in a daf-2 mutant, where DAF-16 is constitutively active, the animals were 
significantly more resistant to Gram-positive pathogens like E. faecalis (GARSIN et al. 2003). 
Therefore, studying IGF/DAF-2 signaling in C. elegans may prove useful for elucidating the 
role of IGF signaling in vertebrate innate immunity.  
Another important immune response signaling cascade in vertebrates is the p38 
MAPK pathway (KIM et al. 2002). Due, in part, to pathogen studies conducted in C. 
elegans, the role of p38 MAPK signaling in mediating innate immune responses has been 
shown to be evolutionarily conserved from C. elegans to humans (KIM et al. 2002). In C. 
elegans, the conserved p38 MAPK cascade is composed of NSY-1, SEK-1 and PMK-1, 
which are orthologs of human ASK1 (apoptosis signal-regulating kinase 1; MAP kinase 
kinase kinase), MKK3 and MKK6 (MAP kinase kinase 3/6) and p38 (MAP kinase), 
respectively (IRAZOQUI et al. 2010b). The importance of the NSY-1-SEK-1-PMK-1 cassette 
cannot be understated as it is involved in infections that occur in the hypodermis (D. 
coniospora) and the intestine (P. aeruginosa, S. aureus, and E. faecalis) in C. elegans ((KIM 
et al. 2002; PUJOL et al. 2008; SHIVERS et al. 2009; SIFRI et al. 2003), unpublished). In 
mammals, LPS (lipopolysaccharide)-induced reactive oxygen species (ROS) production 
results in activation of the p38 MAPK signaling cascade (MATSUZAWA et al. 2005). 
Ultimately, host cytokines are produced that aid in combating sepsis (MATSUZAWA et al. 
2005). A similar system is observed in C. elegans where an unknown signal activates BLI-3 
to produce ROS. The ROS then stimulate the NSY-1-SEK-1-PMK-1 pathway to regulate a 
protective response (VAN DER HOEVEN et al. 2011), (SHIVERS et al. 2010). Thus, two 
ancient, evolutionarily conserved, and connected systems (ROS and the p38 MAPK 
cascade) are used by the host to affect an innate immune response in an evolutionarily 
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conserved manner, again implicating the usefulness of studying C. elegans with respect to 
mammalian innate immunity. 
Reactive oxygen species (ROS) in innate immune responses 
ROS, such as H2O2, are not limited to being cytotoxic effectors during a host 
response to injury and/or infection. ROS can serve as secondary messengers to mediate 
chemotaxis of leukocytes or serve as a substrate in the cross-linking of plant cell walls in 
response to pathogen (DESIKAN et al. 1998), (NIETHAMMER et al. 2009). Therefore, I will 
discuss how ROS serve as both indirect and direct effectors of the host immune response 
during infection. 
It was demonstrated by Niethammer et al. that wounding the Zebrafish’s, Danio 
rerio, tail fin resulted in the rapid recruitment of leukocytes to the site of injury (NIETHAMMER 
et al. 2009). During the wounding response, they observed a rapid and significant increase 
in H2O2 levels at the site of injury that coincided with leukocyte extravasation (NIETHAMMER 
et al. 2009). The monitoring of global H2O2 levels was accomplished by introducing HyPer 
mRNA, by injection, into Zebrafish embryos (NIETHAMMER et al. 2009). The HyPer system 
relies on the bacterial OxyR::YFP transcription factor fusion that allows for determination of 
H2O2 levels, as it is highly specific to H2O2 (NIETHAMMER et al. 2009). Through the use of 
morpholinos (antisense oligomers used for RNAi; RNA interference) against Duox and an 
NADPH oxidase chemical inhibitor (DPI; diphenyleneiodinium chloride) they determined 
that the dual oxidase, Duox, was responsible for the H2O2 gradient (NIETHAMMER et al. 
2009). Additionally, through RNAi and chemical inhibition of H2O2 by antioxidants, they 
determined that leukocyte recruitment to the wounded tail fin was dependent on the Duox-
produced H2O2 gradient (NIETHAMMER et al. 2009). Thus, they demonstrated for the first 
time that Duox-produced ROS mediated the efficient recruitment of leukocytes to an injury 
site in a paracrine-dependent manner (NIETHAMMER et al. 2009). 
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While ROS are important as signaling molecules in the immune response of many 
eukaryotic species, scientists rarely consider their importance in plants. Three plant species 
Arabidopsis thaliana, Glycine max (soybean), and Nicotiana tabacum have been paramount 
in the understanding of how ROS, such as H2O2, contribute to plant innate immunity, 
especially with respect to the hypersensitive response (HR)—a form of programmed cell 
death (PCD) (DESIKAN et al. 1996), (DESIKAN et al. 2000), (LEVINE et al. 1994), (LEVINE et 
al. 1996), (TENHAKEN et al. 1995). HR is a very specialized feature of non-host resistance in 
which an entire plant cultivar displays resistance to infection by a microbial pathovar 
(DESIKAN et al. 1996), (LEVINE et al. 1994), (TENHAKEN et al. 1995). The HR response is 
initiated by a plant disease resistance (R) protein specifically recognizing its cognate Avr 
(avirulence) effector molecule produced by a pathogen (ROJAS and MYSORE 2012), (ROJAS 
et al. 2012). Upon recognition of the Avr, an oxidative burst is triggered. Two major 
producers of the H2O2 in response to infection are respiratory burst oxidase homologs 
(RBOHs i.e. NADPH oxidases; NOXs) and glycolate oxidases (GOXs). Similar to NOX in 
animals, RBOH enzymes produce superoxide (O2-) that dismutates into H2O2—this reaction 
is catalyzed by a superoxide dismutase (SOD). However, GOX produces H2O2 directly as a 
byproduct of the glyoxylate reaction in which glycolate and O2- are the substrates (ROJAS 
and MYSORE 2012), (ROJAS et al. 2012). In response to nonhost pathogen elicitors, it was 
determined that the soybean reinforces its cell wall as treatment with a pectinase and 
cellulose mixture, used by microbes to gain entry into plant cells, displayed a 50% reduction 
in their ability to generate protoplasts with respect to uninfected soybean suspensions 
(BRADLEY et al. 1992), (BRISSON et al. 1994). The elicitor-induced increase in cell wall 
strength was determined to be the result of oxidative cross-linking of p100 and p33, a 
(hydroxyl)proline-rich protein (HRGP) and proline-rich protein (PRP), respectively (BRADLEY 
et al. 1992), (BRISSON et al. 1994), (TENHAKEN et al. 1995). Excitingly, it was determined 
that H2O2 was required for this (elicitor-induced) oxidative cross-linking, as the presence of 
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the antioxidants ascorbate or catalase precluded oxidative cross-linking, regardless of the 
elicitor being present or absent (BRADLEY et al. 1992), (BRISSON et al. 1994), (TENHAKEN et 
al. 1995). Additionally, production of tyrosine-rich proteins such as HGRPs and PRPs is 
upregulated during this rapid response, which is interesting as tyrosine residues serve to 
cross-link structural proteins such as collagens in the C. elegans cuticle (THEIN et al. 2009). 
It is thought that this rapid host response is meant to prevent further invasion and trap these 
pathogens within cells destined for HR, allowing time for the production of antimicrobials 
such as phytoalexin (BRADLEY et al. 1992), (BRISSON et al. 1994). 
Once the H2O2 concentration threshold (6 mM) has been surpassed, HR-mediated 
PCD occurs only in the infected cells in a calcium-mediated fashion similar to apoptosis in 
mammalian cells (LEVINE et al. 1996). At a concentration of 2 mM, H2O2 induces 
transcription of glutathione S-transferase (gst) as well as glutathione peroxidase (gpx), both 
of which are involved in protecting the cell from oxidative stress (LEVINE et al. 1994), 
(LEVINE et al. 1996), (TENHAKEN et al. 1995). While the infected cells are destined for PCD 
this is not necessarily the case for the surrounding adjacent, uninfected, cells.  Because 
H2O2 is a membrane permeable molecule it diffuses out of the infected cells and conditions 
the surrounding cells through upregulating expression of oxidative stress genes such as gst 
and gpx (LEVINE et al. 1994), (LEVINE et al. 1996), (TENHAKEN et al. 1995). It is speculated 
that the adjacent cells do not undergo HR because the upregulation of the oxidative stress 
response genes prevent toxic levels of H2O2 accumulation, thus ameliorating the spread of 
PCD (LEVINE et al. 1994), (LEVINE et al. 1996), (TENHAKEN et al. 1995). 
Another interesting example of infection-induced ROS signaling that contributes to 
the host’s immune response involves Erwinia carotovora Ecc15 and D. melanogaster larvae 
(WU et al. 2012). Wu et al. elegantly demonstrated that ingestion of Ecc15 by D. 
melanogaster larvae resulted in immunological communication between the intestine and 
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fat body organs (WU et al. 2012). The fat body is an important organ in the innate immune 
response of Drosophila larvae, akin to the liver (WU et al. 2012). While infection resulted in 
H2O2 production at the site of infection i.e. the gut, H2O2 was not involved in modulating 
expression of the antimicrobial peptides (AMPs) drosomycin (Drs) and diptericin (Dpt) in the 
gut, however, it did modulate expression of Drs and Dpt in the fat body (WU et al. 2012). In 
another study, in response to intestinal infection by Ecc15, nitric oxide synthase (NOS) 
expression was markedly induced causing a concomitant increase in NO (FOLEY and 
O'FARRELL 2003). Through chemical and genetic methods it was determined that NO acts 
as a signaling molecule during the larvae’s immune response to activate hemocytes (FOLEY 
and O'FARRELL 2003). These hemocytes then act on the fat body ultimately resulting in the 
production of Dpt, which contributes to the host’s immune response (FOLEY and O'FARRELL 
2003). Additionally, it was demonstrated that intestinal H2O2-induced expression of Dpt was 
modulated in a NO-dependent manner; however, Drs expression was not significantly 
affected by NO (WU et al. 2012). Thus intestinal H2O2 modulated the expression of NO to 
affect the expression of Dpt in the fat body, while the same intestinal H2O2 was necessary 
and sufficient for inducing expression of Drs in the fat body (WU et al. 2012). 
One final example of how ROS acts as a secondary messenger in response to 
infection involves NOD2 and NF-κB in the human intestine (LIPINSKI et al. 2009). NOD2 
belongs to the NOD-like receptor (NLR) family and is well-documented in modulating innate 
immune signaling in response to muramyl dipeptide (MDP), a constituent of peptidoglycan, 
by ultimately promoting nuclear localization of NF-κB ((LIPINSKI et al. 2009); reviewed by 
(CORREA et al. 2012)). In this study, Lipinski et al. determined that activation of NOD2 by 
MDP or TNFα resulted in the upregulation in transcription and translation of DUOX2 in 
Caco-2 cells (human colonic epithelial adenocarcinoma cell line) and ultimately increased 
production of ROS (LIPINSKI et al. 2009). Like primary human intestinal epithelial cells, 
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Caco-2 cells produce DUOX2 (EL HASSANI et al. 2005b). It was demonstrated in both Caco-
2 and HEK293 (human embryonic kidney) cells that cellular invasion by Listeria 
monocytogenes was significantly reduced when NOD2 or DUOX2 were present. However, 
the presence of both NOD2 and DUOX2 produced a greater reduction in cellular invasion 
suggesting a synergistic effect with respect to the host immune response (LIPINSKI et al. 
2009). Furthermore, infected HEK293 cells expressing NOD2 that were transfected with 
siRNA (small inhibitory RNA) against duox2 displayed decreased ROS levels (LIPINSKI et al. 
2009). Knock down of duox2 in NOD2-expressing Caco-2 cells displayed increased cellular 
invasion thus further supporting the NOD2-dependent increase in ROS production by 
DUOX2 (LIPINSKI et al. 2009). Because NF-κB can be turned on by NOD2-mediated 
signaling or through H2O2, Lipinski et al. decided to determine if DUOX2 was involved in 
NOD2-mediated activation of NF-κB (LIPINSKI et al. 2009). Through the NF-κB luciferase 
reporter assay they demonstrated that DUOX2-generated H2O2, which was enhanced by 
MDP, further stimulated NOD2-mediated NF-κB activation (LIPINSKI et al. 2009). 
NADPH Oxidase (NOX)/ Dual Oxidase (DUOX) family 
I have discussed how ROS, particularly H2O2, are important as secondary 
messengers in innate immune signaling by the host. However, I have yet to delve into how 
ROS can act as direct immune effectors against pathogens. While H2O2 is an oxidant, it is 
not as effective at killing pathogens as other ROS e.g. HOCl, HOI, HOBr, or HOSCN 
(hypochlorous, hypoiodous, hypobromous, and hypothiocyanous acid, respectively). In this 
part of the introduction, I will discuss how ROS are potent microbicidal effectors produced 
by the host in response to infection. However, I must also include how these ROS are 
generated which requires elaboration on NADPH Oxidases (NOX) and Dual Oxidases 
(DUOX) as well as the peroxidases that use the H2O2 to catalyze the formation of these 
microbicidal ROS. 
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gp91phox, now known as NOX2, is the archetypal member of the NOX/DUOX family, 
as it was the first discovered protein of the NOX/DUOX family. More importantly, the 
gp91phox subunit of the heterodimeric flavocytochrome b558 complex, the catalytic center, is 
highly conserved in the rest of the NOX/DUOX members (reviewed by (NAUSEEF 2014)). 
Other features of NOX2 that are conserved in the NOX/DUOX family include two 
membrane-embedded prosthetic heme groups, as well as the FAD and NADPH binding 
domains (reviewed by (RADA and LETO 2008)). The heme moieties allow for the transfer of 
electrons from the cytosol into the phagosomal compartment, in the case of NOX2, or the 
extracellular space in the case of DUOX (MEIER et al. 1993), (YU et al. 1998). In neutrophils 
and macrophages, activated NOX2 is comprised of membrane bound flavocytochrome b558 
complex (gp91phox and p22phox), cytosolic p47phox/p40phox/p67phox complex as well as the 
cytosolic GTPase Rac2. This NOX2 complex is present in the phagolysosome membrane 
and is responsible for the respiratory burst observed in response to engulfed bacterial and 
fungal pathogens (JACKSON et al. 1995).  
The respiratory burst is an important facet of the host’s innate immune response 
mediated by neutrophils, and macrophages, as evidenced by the X-linked and autosomal 
recessive forms of chronic granulomatous disease (CGD), characterized by a nonfunctional 
NOX2 multiprotein complex (JACKSON et al. 1995). Approximately 60% of patients exhibit 
the X-linked form of CGD which is due to a mutation in gp91phox; however, mutations in 
genes encoding p22phox, Rac2, p40phox, p67phox and p47phox result in CGD (ELLSON et al. 
2006), (JACKSON et al. 1995), (KNAUS et al. 1991). Phagocytosis of pathogens is not 
impaired in CGD neutrophils or macrophages, but there is a reduction in the consumption of 
O2, which is reduced to O2-, which rapidly dismutates into H2O2 (COHEN et al. 1981), 
(HENRIET et al. 2012). Additionally, there is a high occurrence of granuloma formation due 
to macrophages being unable to efficiently kill the pathogen (COHEN et al. 1981). CGD 
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patients are also characterized by frequent, severe infections by catalase positive bacteria 
and fungi such as S. aureus, Candida albicans and Aspergillus nidulans; however, catalase 
negative bacteria such as Streptococci are efficiently eliminated by CGD neutrophils 
(COHEN et al. 1981).  
While H2O2 production is necessary for the respiratory burst, it is not the main 
mediator of microbicidal activity in the phagolysosome. HOCl resulting from the reaction of 
H2O2 and chloride ions catalyzed by myeloperoxidase (MPO) is the major microbicidal 
oxidant produced in the phagolysosome. Neutrophils in MPO-deficient patients are unable 
to efficiently kill C. albicans which corresponds to findings in CGD patients thus indicating 
that both H2O2 and MPO are very important for candidacidal activity and prevention of 
disseminated candidiasis (BEILKE et al. 1989), (HAMPTON et al. 1998), (KLEBANOFF et al. 
2013), (LEHRER 1970). While HOCl is a very potent antimicrobial, its method of action within 
the phagolysosome was unknown for the longest time until it was observed that protein 
bound 3-chlorotyrosine was a marker for HOCl-mediated oxidation (CHAPMAN et al. 2002), 
(ROSEN et al. 2002). Formation of 3-chorotyrosine in E. coli and S. aureus proteins occurred 
when either organism was engulfed by neutrophils that were wild type for H2O2 production 
and hMPO (human) expression (CHAPMAN et al. 2002), (KLEBANOFF et al. 2013), (ROSEN et 
al. 2002). When MPO-deficient or CGD neutrophils were incubated with E. coli, a marked 
decrease in 3-chlorotyrosine was observed in the recovered E. coli proteins (ROSEN et al. 
2002), (KLEBANOFF et al. 2013). Additionally, there was a positive correlation in E. coli and 
S. aureus death and 3-chlorotyrosine bound protein, suggesting that in wild type neutrophil 
phagolyosomes the H2O2-MPO-Cl- system produces HOCl, a highly microbicidal oxidant, 
that chlorinates the engulfed bacteria (CHAPMAN et al. 2002), (KLEBANOFF et al. 2013), 
(ROSEN et al. 2002). Another way that HOCl contributes to microbicidal killing in the 
phagolysosome is through the production of chloramines such as monochloramine (NH2Cl) 
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(BEILKE et al. 1989), (HAMPTON et al. 1998), (KLEBANOFF et al. 2013). Monochloramine is a 
potent microbicidal agent and is able to cross cell membranes more readily than HOCl as 
monochloramine is highly lipophilic (BEILKE et al. 1989), (HAMPTON et al. 1998).  
For years it was viewed that the purposeful production of ROS in response to 
infection was limited to professional phagocytes and any ROS detected in non-phagocytic 
cells was due to mitochondrial leakage ((IDE et al. 1999); reviewed by (NAUSEEF 2014)). 
However, in the past 15 years this view was proven to be incorrect with the discovery of 
several NOX isoforms and two DUOX proteins (Figure 1.1). The revolution in thought began 
with the discovery of NOX1 in the human colon (SUH et al. 1999). NOX3 was discovered to 
be expressed in the inner ear, while NOX4 was expressed in the kidneys (GEISZT et al. 
2000), (PAFFENHOLZ et al. 2004). Interestingly, NOX5 possesses an extra N-terminal 
cytosolic arm that contains four Ca2+-binding EF-hands which is sufficient for regulation of 
its activity by binding of Ca2+ (BANFI et al. 2001). NOX5 is found primarily in pachytene 
spermatocytes as well as the lymph nodes and spleen (BANFI et al. 2001). Like NOX5, 
DUOX activity is modulated by Ca2+-binding to their two EF-hands; however, DUOX 
proteins possess an N-terminal, extracellular, peroxidase-like domain (AMEZIANE-EL-
HASSANI et al. 2005),  (MEITZLER and ORTIZ DE MONTELLANO 2009). Expression of the 
DUOX proteins has been observed in a myriad of mammalian tissues including thyroid 
follicle cells as well as mucosal surfaces such as those of the gastrointestinal tract, airways, 
and oral cavity (CONNER et al. 2002), (EL HASSANI et al. 2005a), (FORTEZA et al. 2005), 
(MORENO et al. 2002). DUOX2 was first observed in the apical membrane of thyroid follicle 
cells and was found to contribute to thyroid hormone synthesis by supplying H2O2 to thyroid 
peroxidase (TPO) as hetero- and homozygous mutations in DUOX2 resulted in mild-to-
severe congenital hypothyroidism (MORENO et al. 2002). Congenital hypothyroidism is a 
severe problem for newborn children as thyroid hormone has been linked with brain 
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development and mental retardation (MORENO et al. 2002). While DUOX2’s role in thyroid 
hormone synthesis is appreciated, DUOX2’s role in mucosal defense is equally important 
for the host with respect to microorganisms.  
 While it was known that LPO (lactoperoxidase) was responsible for the production of 
the potent antimicrobial OSCN- in airways, saliva, milk and tears, the source of H2O2 for 
LPO was unknown (GEISZT et al. 2003b), (FORTEZA et al. 2005), (MOSKWA et al. 2007). 
Over the years with the use of several airway animal models including, sheep, rat, bovine, 
and humans it was determined that DUOX 1/2 were responsible for producing the H2O2 
utilized by LPO (FORTEZA et al. 2005), (GEISZT et al. 2003b), (GERSON et al. 2000), 
(MOSKWA et al. 2007), (RADA et al. 2008), (RADA and LETO 2010). At neutral pH, 
hypothiocyanate (OSCN-), the predominant form and conjugate base of HOSCN, is still a 
very potent microbicidal agent produced by the DUOX1/2-LPO-SCN- system in the airways 
of humans (FORTEZA et al. 2005), (RADA et al. 2008), (RADA and LETO 2010). At the 
physiological concentrations present in the airway during an immune response, OSCN- is 
able to efficiently clear S. aureus, P. aeruginosa, and Burkholderia cepacia; however, 
OSCN- does not damage the host’s mucosal epithelial cells in the process, unlike HOCl, 
which is an extremely non-specific and highly toxic oxidant that causes damage to both the 
host and the pathogen (MOSKWA et al. 2007), (RADA and LETO 2010). The DUOX1/2-LPO-
SCN- antimicrobial system in airway mucosal epithelial cells is constitutively active in 
mammals (GERSON et al. 2000), (MOSKWA et al. 2007), (RADA and LETO 2010). Additionally, 
upon detection of the pathogen, P. aeruginosa, significant increases in H2O2 and OSCN- 
are observed, which correlate with enhanced pathogen clearance (RADA and LETO 2010). 
This increase in H2O2, and ultimately OSCN-, is directly attributable to DUOX activity as the 
H2O2 levels are modulated by Ca2+ concentration and DPI, both of which are known to 
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stimulate or inhibit activity, respectively (AMEZIANE-EL-HASSANI et al. 2005), (MOSKWA et al. 
2007), (RADA and LETO 2010). 
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Figure 1.1 Comparison of NOX/DUOX family members A). Phagocytic oxidase (NOX2) 
is structurally similar to NOX1, 3, and 4. Cytosolic NADPH binds to the NADPH binding 
domain and two electrons are transferred from NADPH to the FAD domain. Two, single 
electron transfers are mediated by the FAD domain and the two membrane-embedded 
heme moieties that reduce two equivalents of O2, result in the production of two O2- 
radicals. B). In complexes containing NOX 1, 3, and 4, p40phox is absent. Additionally, NOX 
activating protein 1 (NOXA1) and NOX organizing protein 1 (NOXO1) replace p67phox and 
p47phox, respectively. NOX4 is in parentheses as it produces H2O2 instead of O2-. C). NOX5 
possesses two pairs of calcium-binding motifs in its cytosolic N-terminus. D). DUOX 
proteins possess one pair of calcium-binding hands as well as an extracellular peroxidase-
like domain at their N-terminus (reviewed by (NAUSEEF 2014) and (VIGNAIS 2002). Figure 
adapted from (NAUSEEF 2014). 
Used with permission from Elsevier Limited and Biochimica et Biophysica Acta (BBA).  
NAUSEEF, W. M., 2014 Detection of superoxide anion and hydrogen peroxide production by  
cellular NADPH oxidases. Biochim Biophys Acta 1840: 757-767. 
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In cystic fibrosis patients the CFTR (CF transmembrane conductance regulator) is mutated, 
resulting in impaired SCN- transport into the airway surface liquid (ASL) where LPO and 
H2O2 are located (MOSKWA et al. 2007), (RADA et al. 2008), (RADA and LETO 2010). 
Moskwa et al. genetically restored CFTR in human CF airway epithelial cells (hAEC) and 
observed transport of SCN- across the apical membrane of the hAECs into the ASL 
resulting in OSCN- production and efficient clearance of S. aureus (MOSKWA et al. 2007). 
Thus, CF patients have an impaired oxidative defense system that is unable to efficiently 
clear Gram-positive and –negative pathogens (MOSKWA et al. 2007), (RADA et al. 2008), 
(RADA and LETO 2010).  
In D. melanogaster, it was observed that dDUOX was important during gut infection 
with Ecc15, but not during a systemic infection (HA et al. 2009a), (HA et al. 2009b). 
Restoration of dDUOX under a gut-specific promoter was necessary and sufficient to 
restore wild type resistance during gut infection with Ecc15 (HA et al. 2009a), (HA et al. 
2009b). Interestingly, basal levels of the dDUOX protein were important in mediating gut-
microbe homeostasis as gut-specific RNAi of dDUOX resulted in uncontrolled proliferation 
of the nonpathogenic microbe Saccharomyces cerevisiae (HA et al. 2009a), (HA et al. 
2009b). This uncontrolled proliferation of S. cerevisiae, which serves as a nutrient source, 
ultimately resulted in host death (HA et al. 2009a). However, upon gut infection by Ecc15, 
an increase in ROS production was observed following an increase in dDUOX translation 
(HA et al. 2009a), (HA et al. 2009b). This increase in dDUOX expression was necessary as 
mutants in the p38 pathway resulted in enhanced susceptibility during gut infection (HA et 
al. 2009b). Thus, basal levels of dDUOX are sufficient for maintaining host-microbe gut 
homeostasis in uninfected conditions, but greater amounts of dDUOX are necessary to 
generate an effective ROS response during infection (HA et al. 2009b).  
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In C. elegans, it has been documented that DUOX-1/BLI-3 is important in both the 
host immune response and cuticle biogenesis (CHAVEZ et al. 2009), (THEIN et al. 2009). In 
the latter example, it was observed through a combination of genetics and biochemistry that 
BLI-3 is important in di- and tri-tyrosine cross-link formation (EDENS et al. 2001), (THEIN et 
al. 2009). RNAi knock down of bli-3 resulted in cuticle blistering due to reduced di- and tri-
tyrosine cross-linking of essential collagens DPY-13 and COL-12 (THEIN et al. 2009). A 
slightly more severe blistering phenotype was observed in mlt-7 RNAi animals and mlt-7 
(tm1794) partial deletion mutant animals, which was also due to decreased di- and tri-
tyrosine cross-linking of DPY-13 and COL-12 (THEIN et al. 2009). Additionally, bli-3 (e767); 
mlt-7 (tm1794) double mutants displayed post-embryonic lethality due to severe cuticle 
blistering and were extremely dumpy (THEIN et al. 2009). These results suggest that BLI-3 
supplied H2O2 to both its peroxidase-like domain and MLT-7 for the purpose of cuticle 
cross-linking, as neither protein was sufficient to completely compensate for loss of the 
other’s activity (THEIN et al. 2009). However, upon loss of both proteins, a more significant 
blistered phenotype was observed, suggesting BLI-3 and MLT-7 cooperate together, but 
are in parallel pathways (THEIN et al. 2009). This work by Thein et al. in conjunction with the 
plethora of data on NOX/DUOX-peroxidase immune systems, as well as BLI-3 producing 
H2O2 in response to E. faecalis infection provided much of the rationale for my work (THEIN 
et al. 2009).  
By bli-3 RNAi knock down in intestinal- and hypodermal-specific strains, it was 
determined that BLI-3-produced H2O2 was required for wild type resistance to E. faecalis 
infection (CHAVEZ et al. 2009). Additionally, by the use of two distinct point mutations in BLI-
3’s peroxidase-like domain, it was observed that the peroxidase domain did not significantly 
contribute to host immunity during infection (CHAVEZ et al. 2009). With these data in mind, 
and the previous examples of NOX/DUOX-peroxidase immune responses, I hypothesized 
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that during infection BLI-3 supplies H2O2 to a peroxidase(s) involved in innate immunity. In 
this work, I identify potential immune-related peroxidases and characterize one, SKPO-1, in 
detail. I propose that the BLI-3/SKPO-1 oxidative immune response contributes to C. 
elegans resistance during infection with E. faecalis. The results of my work will be 
discussed in Chapter 3. 
Peroxidase-cyclooxygenase superfamily 
In this penultimate segment, I will discuss the relationship between peroxidases and 
their associated prosthetic heme group and how this defines the peroxidase with respect to 
substrate specificity and reactivity. Additionally, I will briefly touch on the molecular 
phylogeny of some peroxidase protein clades within the peroxidase-cyclooxygenase 
superfamily. Ultimately, these topics will further the molecular understanding of why 
peroxidases such as MPO, LPO and SKPO-1 are important to immunity.  
Minus the oxidation of I- and SCN-, most peroxidases such as horseradish 
peroxidase (HRP) are incapable of oxidizing halide substrates Cl- and Br- under 
physiological pH (HUANG et al. 2005). However, at pH of 5.0, HRP is capable of oxidizing 
Br- and Cl-. While HRP is able to catalyze these reactions under acidic pH, the protein’s 
activity is rapidly decreased resulting in inactivation of HRP by these extremely 
electrophilic, oxidizing agents (HUANG et al. 2005). These (pseudo)hypohalous oxidants 
react with the heme prosthetic group resulting in formation of halide adducts i.e. 
bromoheme (HUANG et al. 2005). Interestingly, the mammalian peroxidases LPO and MPO 
can catalyze the formation of antimicrobial oxidants (OSCN- and HOCl, respectively) 
without inactivating themselves due to the covalent linkages to the heme prosthetic group 
(HUANG et al. 2005); reviewed by (COLAS and ORTIZ DE MONTELLANO 2003), (O'BRIEN 
2000), (ORTIZ DE MONTELLANO 2008). It was determined that when either Asp or Glu were 
mutated that LPO and MPO’s ability to catalyze reactions was reduced due to modification 
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of the heme group during catalytic turnover ((COLAS et al. 2002), (HUANG et al. 2005); 
reviewed by (COLAS and ORTIZ DE MONTELLANO 2003), (ORTIZ DE MONTELLANO 2008)). Not 
only do these covalent ester bonds protect the heme from modification during reactions, but 
they aide in the peroxidase’s redox potential through distortion of the heme’s planarity and 
distribution of electron density (reviewed by (COLAS and ORTIZ DE MONTELLANO 2003), 
(ORTIZ DE MONTELLANO 2008)). 
MPO is unique amongst the mammalian peroxidases as it contains a methionine 
residue that is absent in the other mammalian peroxidases. The presence of this Met 
residue allows for formation of a methionine sulfonium covalent linkage. The positive 
sulfonium bond is electron-withdrawing and is responsible for MPO’s ability to utilize Cl- as 
a substrate, as mutation of Met to the residue at the corresponding position in LPO or TPO 
(Gln or Val, respectively) results in loss of HOCl production (HUANG et al. 2005), (KOOTER 
et al. 1999). While these covalent bonds are important for catalyzing hypohalous acid 
formation they are not necessary for peroxidase activity as they are absent in non-animal 
peroxidases (reviewed by (COLAS and ORTIZ DE MONTELLANO 2003), (ORTIZ DE 
MONTELLANO 2008)). The residues that are necessary for an efficient catalytic site in 
peroxidases are Gln, Asn, His and Arg, all of which are present in LPO, MPO and SKPO-1. 
The distal side of the hMPO-associated heme has three key catalytic residues, Gln257, 
His261, and Arg405 while the proximal side has His503 (reviewed by (COLAS and ORTIZ DE 
MONTELLANO 2003)). In conjunction with H2O2, His261 and Arg405 are critical for formation 
of the heme group’s reactive intermediate compound I (reviewed by (COLAS and ORTIZ DE 
MONTELLANO 2003), (ORTIZ DE MONTELLANO 2008)). The distal His acts as an acid-base 
catalyst while the Arg polarizes the peroxidic (H-O-O-H) bond, resulting in heterolytic 
cleavage and the release of H2O (reviewed by (COLAS and ORTIZ DE MONTELLANO 2003), 
(ORTIZ DE MONTELLANO 2008)). While H2O2 was reduced, the heme was oxidized and the 
two electron oxidizing equivalents are stored as an oxyferryl moiety (Feiv=O) and a π 
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radical cation on the tetrapyrrole ring (reviewed by (COLAS and ORTIZ DE MONTELLANO 
2003), (ORTIZ DE MONTELLANO 2008)). This reaction is observed in animal peroxidases. 
Depending on a peroxidase’s ability to utilize a particular substrate and availability of a 
substrate, two different reactions might occur. All peroxidases, including the non-animal 
superfamily, are able to oxidize phenol-containing substrates such as tyrosine (reviewed by 
(COLAS and ORTIZ DE MONTELLANO 2003)). This peroxidation reaction (R1) is characterized 
by reduction of compound I to compound II and then reduction of compound II to ferric 
heme through two, single electron transfers from two tyrosine phenolic groups resulting in 
two tyrosyl radicals (Figure 1.2). These tyrosyl radicals can react with each other to form 
tyrosine cross-linkages that are essential in thyroid hormone biosynthesis and cuticle 
formation in humans and C. elegans, respectively ((EDENS et al. 2001), (THEIN et al. 2009); 
reviewed by (COLAS and ORTIZ DE MONTELLANO 2003), (ORTIZ DE MONTELLANO 2008)). The 
other possibility is the halogenation reaction (R2), where compound I is reduced to its 
resting state through a simultaneous transfer of two electrons from a halide ion resulting in 
a hypohalous acid—as a result compound II is not formed (Figure 1.2).  
As BLI-3 lacks the distal His residue (Tyr106), its rate of turnover is very low with 
respect to other mammalian peroxidases (MEITZLER et al. 2010). Additionally, in vitro 
studies demonstrated BLI-3 possesses extreme substrate specificity, as it does not readily 
oxidize a general peroxidase substrate (ABTS; 2, 2'-Azino-di(3-ethylbenzthiazoline-6-
sulfonate)). However, BLI-3 readily oxidizes a tyrosine substrate (L-tyrosine ethyl ester) 
(MEITZLER et al. 2010). Meitzler et al. demonstrated that the recombinant Y106H BLI-3 
peroxidase-like domain mutant possessed significantly higher peroxidase activity compared 
to the wild type BLI-3 peroxidase-like domain (~7-fold increase) (MEITZLER et al. 2010). 
However, the Y106H mutant’s ability to oxidize L-tyrosine ethyl ester was still 170-fold lower 
than bovine LPO (MEITZLER et al. 2010). Thus, it is highly unlikely that BLI-3 is capable of 
utilizing its own H2O2 for an antimicrobial purpose due to the inefficiency of its peroxidase-
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like domain, which may explain its functional association with MLT-7 for cross-linking the 
cuticle (EDENS et al. 2001), (MEITZLER et al. 2010), (THEIN et al. 2009). These results further 
support the rationale that one or more additional peroxidases functionally interact with BLI-3 
to contribute to the host’s immune response against E. faecalis. 
Within the peroxidase-cyclooxygenase superfamily it has been suggested, by 
evolutionary genetics, that the mammalian peroxidase subfamily evolved from the 
“traditional” nematode peroxidasin subfamily (ZAMOCKY et al. 2008), (SOUDI et al. 2012). 
Peroxidasins and peroxinectins are multi-domain proteins that possess multiple leucine-rich 
repeats (LRR) and immunoglobulin-like (Ig) domains in addition to the peroxidase domain 
(ZAMOCKY et al. 2008), (SOUDI et al. 2012). Interestingly, mature mammalian peroxidases 
are structurally similar to a different group of nematode peroxidasins termed short 
peroxidasins, as both mammalian peroxidases and short peroxidasins lack LRRs and Ig 
domains (ZAMOCKY et al. 2008), (SOUDI et al. 2012). It has been proposed that the short 
peroxidasin group is a link between the peroxinectin and traditional nematode peroxidasin 
subfamilies (ZAMOCKY et al. 2008), (SOUDI et al. 2012). As SKPO-1 lacks LRRs and Ig 
domains, it is classified as a short peroxidasin (ZAMOCKY et al. 2008), (SOUDI et al. 2012). 
However, SKPO-1 does possess a Shk toxin (ShkT)-like domain. In the sea anemone, 
Metridium senile, the ShkT protein family was characterized as a potassium channel 
blocker (TILLER and GARSIN 2014). However in C. elegans, the ShkT-like domain lacks the 
necessary residues to block potassium ion channels (TILLER and GARSIN 2014). Currently, it 
is thought that the ShkT-like domain mediates protein-protein interactions in nematodes 
(TILLER and GARSIN 2014). With respect to nematodes, the ShkT-like domain’s function has 
yet to be experimentally determined (TILLER and GARSIN 2014).  
In crustaceans, peroxinectins (PXT) are important in the host’s innate immune 
response and their expression increases upon detection of PAMPs (β-1,3 glucan and LPS) 
and/or (opportunistic marine) pathogens (S. aureus, Vibrio harveyi), ((DONG et al. 2011), 
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(DU et al. 2013), (JOHANSSON et al. 1995), (JOHANSSON et al. 1999), (LIU et al. 2004), 
(VIZZINI et al. 2013); reviewed by (CERENIUS et al. 2008)). Upon detection of infection, PXTs 
are exocytosed from granular hemocytes to aid in hemocyte cell-adhesion and opsonization 
(DONG et al. 2011), (DU et al. 2013), (JOHANSSON et al. 1999), (LIU et al. 2004), (VIZZINI et 
al. 2013); reviewed by (CERENIUS et al. 2008). These PXTs bind to hemocytes by their 
integrin-binding motif and also by binding to an extracellular superoxide dismutase (EC-
SOD) (DONG et al. 2011), (DU et al. 2013), (JOHANSSON et al. 1999), (LIU et al. 2004), 
(VIZZINI et al. 2013); reviewed by (CERENIUS et al. 2008). Upon degranulation, the PXTs are 
proteolytically processed and gain peroxidase activity. It has been proposed that the EC-
SOD/PXT complex may produce hypohalous acids; however, this is still unknown 
(JOHANSSON et al. 1999), (VIZZINI et al. 2013); reviewed by (CERENIUS et al. 2008). It has 
been demonstrated that MPO readily binds to the plasma membrane of neutrophils by the 
CD11b/CD18 integrins resulting in enhanced degranulation, respiratory burst activity as well 
as increased CD11b surface presentation (LAU et al. 2005). Strangely, the function(s) of 
peroxidasins (PXN) in D. melanogaster is relatively unknown besides their expression in 
hemocytes, which is important in phagocytosis as well as deposition of ECM (GOTENSTEIN 
et al. 2010). Likewise in C. elegans, peroxidasins are new territory. It was demonstrated 
that PXN-2, but not PXN-1, was crucial for post-embryonic basement membrane integrity 
and muscle attachment to the hypodermis (GOTENSTEIN et al. 2010). Additionally, even less 
is known about short peroxidasins; however, my research on SKPO-1 has demonstrated its 
involvement in the host’s immune response. 
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Figure 1.2 Heme, iron protoporphyrin IX, is the prosthetic group in both the non-
animal (bacterial, fungal, plant) and peroxidase-cyclooxygenase superfamilies. Within 
the peroxidase-cyclooxygenase superfamily, mammalian peroxidases possess covalently 
bound heme, which is not present in members of the non-animal superfamily. A). 
Unincorporated heme prosthetic group. The red text denotes the three sites that are able to 
form a covalent linkage between the heme and peroxidase. B). Most mammalian 
peroxidases, represented by LPO, are capable of forming two covalent bonds at the 1- and 
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5-methyl positions (Glu375 and Asp225, respectively). C). MPO is unique because it can 
form a third covalent, sulfonium, bond with its heme group at the 2-vinyl position in addition 
to the 1- and 5-methyl covalent bonds. In the 3D model of MPO-associated heme, there are 
three ester linkages denoted by the red (D260 and E408) and yellow (M409) bonds—the 
asterisks are meant as an additional visual aide. D). SKPO-1 is unable to form covalent 
bonds with its heme prosthetic group at 1- and 5-methyl positions due to the absence of the 
Asp and Glu residues (replaced with Ser221 and Leu335, respectively). As seen with MLT-
7, the heme prosthetic group is noncovalently associated with SKPO-1. R1 is the 
peroxidation reaction that is responsible for production of organic radicals such as tyrosyl. 
R2 is the halogenation reaction and is responsible for antimicrobial (pseudo)hypohalous 
acid formation. AH = organic substrate; X- = halide substrate ((TILLER and GARSIN 2014), 
(ZAMOCKY et al. 2008); reviewed by (COLAS and ORTIZ DE MONTELLANO 2003), (ORTIZ DE 
MONTELLANO 2008)). 
Used with permission from John Wiley and Sons and Proteins: Structure, Function, and  
Bioinformatics. ZAMOCKY, M., C. JAKOPITSCH, P. G. FURTMULLER, C. DUNAND and C.  
OBINGER, 2008 The peroxidase-cyclooxygenase superfamily: Reconstructed evolution of  
critical enzymes of the innate immune system. Proteins 72: 589-605. 
Used with permission from Dr. Paul Ortiz de Montellano (personal communication). 
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Significance 
Throughout this introduction, I have conveyed the importance of studying ancient, 
evolutionarily conserved immune responses by using a variety of model organisms. As C. 
elegans is a genetically tractable model, it has proven to be useful for dissecting conserved 
features in a variety of host innate immune responses. Additionally, I have briefly covered 
some of the various physiological processes in which ROS are involved with respect to the 
host immune response. By doing so, I have shown the importance of ROS, particularly 
H2O2, in the host immune response as both a secondary signaling molecule as well as a 
microbicidal effector. Interestingly, for H2O2 to be an effective antimicrobial agent it must be 
converted into a more potent oxidant, such as a hypohalous acid, which requires 
peroxidase involvement. These NOX/DUOX-peroxidase systems are incredibly important in 
the war against viral, fungal, parasitic, and bacterial infections. It is notable that the use of 
an oxidative defense system arose prior to professional phagocytic cells and to adaptive 
immunity, neither of which are present in C. elegans.  
Previously, Chavez et al. demonstrated that in response to infection, C. elegans 
dramatically increased H2O2 production in a BLI-3-dependent manner to contribute to the 
host immune response (CHAVEZ et al. 2007), (CHAVEZ et al. 2009). My work built upon the 
BLI-3-produced H2O2 response during E. faecalis infection of C. elegans. As I have 
recounted, H2O2 by itself, is a poor antimicrobial oxidant and serves as a co-substrate in 
conjunction with a halide for a peroxidase to catalyze the formation of a potent 
antimicrobial. In my work, I demonstrated that SKPO-1 is a peroxidase that uses BLI-3-
produced H2O2 during E. faecalis infection to protect the host. Additionally, I discovered that 
this BLI-3/SKPO-1 system is present and active at an underappreciated host-pathogen 
interface, i.e. the hypodermis and not the intestine, in C. elegans. While I have determined 
that SKPO-1 requires BLI-3-produced H2O2 to contribute to host resistance during E. 
faecalis infection, I do not know how SKPO-1 utilizes the H2O2.  One possibility is that 
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SKPO-1 uses H2O2 to produce a hypohalous acid to kill the pathogen. Another is that 
SKPO-1 could be using the H2O2 to reinforce the cuticle barrier. Finally, SKPO-1 may be 
acting as an antioxidant to prevent cellular damage from excessive H2O2 production. These 
possibilities are not mutually exclusive; SKPO-1 may be involved in each of these 
processes during infection. 
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Chapter 2: Materials and Methods 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Portions of this chapter are based on my first author publication. The Genetics Society of 
America (GSA) journal of Genetics does not require me to obtain permission to reproduce 
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publication. The article is listed for reference: TILLER, G. R., and D. A. GARSIN, 2014 The 
SKPO-1 Peroxidase Functions in the Hypodermis To Protect Caenorhabditis elegans from 
Bacterial Infection. Genetics. 
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Creation of cDNA pL4440 constructs for dsRNA production in E. coli 
A standard RNA isolation procedure was used to procure total RNA from healthy N2 adults 
grown on E. coli OP50 (VAN DER HOEVEN et al. 2011). I followed the first-strand cDNA 
synthesis protocol from the Life Technologies SuperScript® III Synthesis System to 
produce first-strand total cDNA. I then followed a standard PCR protocol using primers 
specific to F32A52.A, F32A52.B and ZK994.3, respectively (primers listed in Table 2.2). 
PCR products were digested and ligated into pL4440 and transformed into chemically 
competent E. coli HT115 to produce dsRNA to the gene-of-interest, respectively. 
C. elegans strains and maintenance 
C. elegans strains were grown and maintained as previously described (HOPE 1999). The 
strains used for the hypodermal and intestinal RNAi studies are as follows: rde-1(ne219); 
Is[wrt-2prom::RDE-1::unc54 3’utr; myo2p::RFP3] and sid-1(qt9); Is[vha-6::sid-1], 
respectively. The RB1437 [skpo-1 (ok1640) II] strain is a partial deletion mutant for skpo-1 
and was verified via sequencing (www.WormBase.org). The RB1437 [skpo1 (ok1640) II] 
strain was created by the C. elegans Reverse Genetics Core Facility at UBC, part of the 
International C. elegans Gene Knockout Consortium and obtained through the 
Caenorhabditis Genetics Center. The independent lines of skpo-1 strains, GF89, GF90 and 
GF91, were obtained through backcrossing the RB1437 [skpo-1 (ok1640) II] strain with the 
wild type N2 Bristol strain five times (B.C. x 5).  
Tiller and Garsin 2014 
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RNAi Interference 
RNAi was performed by exposing L1 through L4 stage larvae to E. coli HT115 expressing 
dsRNA to target genes. RNAi clones were obtained from the C. elegans library (FRASER et 
al. 2000) (KAMATH et al. 2003). skpo-1 worms exposed to pathogens were prone to a 
maternal bagging phenotype therefore cdc-25.1 RNAi was used to induce sterility in some 
experiments (VAN DER HOEVEN et al. 2011). 
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Survival and Longevity Assays 
Unless otherwise indicated, these bacterial strains were used OP50 (E. coli) (BRENNER 
1974), OG1RF (E. faecalis) (DUNNY et al. 1978), and PA14 (P. aeruginosa) (RAHME et al. 
1995). Exposure to RNAi, survival assays, and longevity assays were performed as 
previously described (GARSIN et al. 2001) (GARSIN et al. 2003) (KIM et al. 2002) (VAN DER 
HOEVEN et al. 2011). Briefly, for E. faecalis survival assays, E. faecalis grown in Brain Heart 
Infusion (BHI) medium for 5 hours was seeded (10 ul) onto BHI plates (gentamycin 50 
ug/ml) and incubated at 37˚C for 24 hours. While for P. aeruginosa survival assays, P. 
aeruginosa was cultured in Luria broth (LB) overnight at 37˚C, seeded (10 ul) onto slow-
killing plates and incubated first for 24 hours at 37˚C and then for the duration of the 
experiment at 25˚C (VAN DER HOEVEN et al. 2011). For the E. coli longevity assays, 20X E. 
coli was seeded (100 ul) onto Nematode Growth (NG) medium plates supplemented with 
FUDR (5-Fluoro-2’-deoxyuridine; 25 ug/ml) and streptomycin (25 ug/ml). Seeded NG plates 
were incubated at 25˚C for 24 hours. In all assays, a total of 90 L4 larvae were transferred 
to three replica plates and the assay performed at 25˚C. Worms were scored as live and 
dead at various time points.  
Tiller and Garsin 2014 
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Amplex Red assay for H2O2 measurements 
The Amplex Red hydrogen peroxide/peroxidase kit (Invitrogen Molecular Probes, Eugene, 
OR) was previously adapted to C. elegans to measure pathogen-stimulated hydrogen 
peroxide release (CHAVEZ et al. 2009) (CHAVEZ et al. 2007). The same protocol was 
followed with the following modifications. L4 worms were exposed to a bacterial strain for 
12 hours, and the fluorescence of 30 worms per well was measured after 30 minutes of 
incubation with Amplex Red (540/590 nm excitation and emission, respectively). 80 uM 
diphenyleneiodinium chloride (DPI) (TCI Tokyo, Japan) was added to some wells and 
allowed to incubate for 15 minutes prior to addition of Amplex Red, HRP and Na2PO4 (pH 
7.4) and fluorescence was measured as above.  
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Protein Expression and Purification 
Standard molecular cloning was used to generate and introduce wild type skpo-1 cDNA into 
pET-29b(+) and pET-28a(+) vectors. I isolated total RNA from healthy N2 adults grown on 
E. coli OP50. I followed the first-strand cDNA synthesis protocol from the Life Technologies 
SuperScript® III Synthesis System to produce first-strand total cDNA. I then followed a 
standard PCR protocol using primers specific to full-length skpo-1 (Table 2.2). Standard 
transformation was used to introduce the SKPO-1::HIS6-containing, full-length and 
peroxidase domain versions, and empty vector constructs into E. coli BL21 (DE3). 
Expression and purification of the various constructs was carried out according to 
Novagen® and Clontech Laboratories TALON® protocols, respectively. 
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Western Blot 
Using a semi-dry transfer, protein samples were transferred to a nitrocellulose membrane 
from a 10% SDS-PAGE gel. The nitrocellulose membrane was blocked with 5% non-fat 
milk in TBS-T for 30 minutes in the walk-in 4˚ C on a rocking platform. The membrane then 
incubated with 5% non-fat milk TBS-T and THE™ His Tag, mouse, mAb (1:5,000) for 60 
minutes, rocking, at room temperature. The membrane was then washed with 5% non-fat 
milk TBS-T, ten minutes each, four times. The membrane was then incubated with 5% non-
fat milk TBS-T and goat anti-mouse HRP-conjugated secondary (1:20,000) for 30 minutes, 
rocking, at room temperature. Again, the membrane was washed four times, ten minutes 
each, with 5% non-fat milk TBS-T. Finally, the membrane was incubated with Thermo 
Scientific SuperSignal® Dura Extended Duration Substrate ECL (enhanced 
chemiluminescence) for five minutes and then the membrane was imaged using the BioRad 
ChemiDoc™. This procedure was used for both E. coli and whole worm lysates. In the case 
of detecting SKPO-1 in whole worm lysates, the primary and secondary antibodies used 
were anti-SKPO-1 polyclonal antibody and goat anti-rabbit HRP-conjugated secondary 
(1:1,000 and 1:5,000), respectively. 
Indirect Immunofluorescence 
Immunofluorescence for C. elegans was performed according to Seydoux and Dunn on 
young adult animals (SEYDOUX and DUNN 1997). Custom peptide synthesis, rabbit 
immunization and affinity purification of the SKPO-1 polyclonal antibody was performed by 
LifeTein® (South Plainfield, NJ). The CRVGRRAFDIENGSR peptide corresponds to the C-
terminus of the C. elegans protein SKPO-1. Adult N2 and GF89 worms were imaged using 
an Olympus IX81 automated inverted microscope and Slidebook (version 5.0) software 
along with the SKPO-1 polyclonal primary antibody and Alexa Fluor 488 goat anti-rabbit IgG 
secondary antibody to localize SKPO-1 in C. elegans.  
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Immunogold Labeling and Transmission Electron Microscopy 
Approximately 1,000 N2 and GF89 animals were raised under standard conditions to the 
young adult stage. They were rinsed off of the propagation plates with M9 and spun down 
at 2000 RPM for 1 minute. The worms were sequentially resuspended and pelleted 3 times 
in 1 ml M9 (HOPE 1999). After the final wash they were resuspended in 1 ml 3% formalin, 
0.15% glutaraldehyde in Millonig’s buffer pH 7.45 and fixed for three days at 40°C. Then 
the buffer was drawn off and the samples were incubated in 0.1% fresh made sodium 
borohydride in Millonig’s buffer (RT (room temperature), 10 min). This was followed by 
incubations in Millonig’s buffer (RT, 10 minutes, repeated twice). The samples were then 
dehydrated at room temperature by incubating in 50% ethanol (10 min, twice) and 70% 
ethanol, (15 min, twice). The samples were then permeated with 50% LR-White resin and 
50% ethanol for 60 min, followed by an overnight incubation at room temperature in 50% 
LR-White resin sealed on a rotator. The samples were then incubated at room temperature 
for four hours in 70% LR-White resin and then for five hours in 100% LR-White resin, while 
on a rotator. The pellets were then sealed into BEEM capsules and allowed to polymerize in 
a 53°C oven overnight.120nm thin sections of the LR-White blocks were cut using a 
DiATOME diamond knife and a Leica Ultracut R microtome. Sections were floated onto 200 
mesh nickel grids. The grids were then floated in 50mM glycine (RT, 15 min) and then 
washed twice by floating in drops of PBS. The samples were blocked by floating them for 
30 min in Aurion Blocking Solution followed by washes in incubation buffer (PBS with 0.1% 
Aurion BSA-C) (5 min, three times). The SKPO-1 antibody was diluted into the incubation 
buffer at 1:1000 and the grids were incubated for 1.5 hours at RT. This was followed by 
washes in incubation buffer (10 min, four times) and then incubation with the secondary 
antibody (EMS Goat-Anti-Rabbit IgG with 10 nm gold) diluted 1:20 in incubation buffer. The 
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samples were washed again in incubation buffer (10 min, five times) followed by PBS (10 
min, three times). A post-fix treatment of 3% glutaraldehyde was applied for 10 min followed 
by a final wash with distilled water (5 min, 2 times). The grids were dried in a 70°C oven 
and then imaged using a JEOL 1200 transmission electron microscope at 60 kv and 
captured with a 2k x 2k Gatan CCD camera. 
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RNA isolation and qRT-PCR  
Prior to RNA isolation, wild type and skpo-1 mutant animals were grown on cdc-25.1 
dsRNA expressing E. coli HT115 from the egg to L4 larval stage. L4 animals were then 
exposed to either cdc-25.1 RNAi or E. faecalis OG1RF for 18 hours. The RNA was isolated 
using Trizol (Invitrogen) according to the manufacturer. RNA samples were treated with 
DNase I to eliminate contaminating DNA by the Turbo DNA free kit (Applied Biosystem) 
according to the manufacturer. qRT-PCR was performed as described in (VAN DER HOEVEN 
et al. 2011). Primers used are listed in Table 2.2 (act-1 served as the reference gene). 
 Tiller and Garsin 2014 
Bacterial Colonization 
The CFU analysis was conducted similar to (Breger et al. 2007). Briefly, L4 wild type 
and skpo-1 mutant animals grown on E. coli OP50 were exposed to 100 mm BHI 
gentamycin 10 ug/mL plates seeded with 100 ul of E. faecalis OG1RF for either 12 or 36 
hours at 25˚ C. Worms were washed 3 times with M9 buffer at 1.4 rpm. Worms were then 
washed twice with 25 mM tetramisole hydrochloride to prevent ingestion of the antibiotic 
treatment. Worms were incubated at room temperature for 60 minutes in 25 mM tetramisole 
hydrochloride supplemented with ampicillin and kanamycin, both at 1 mg/mL, to kill surface-
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attached E. faecalis. Worms were collected at 1.4 rpm and washed twice with 25 mM 
tetramisole hydrochloride prior to grinding. Ten worms in 10 ul were transferred to 200 ul of 
M9 and ground for 1 minute using a motorized pestle (Kontes cordless cat# K749540-0000 
and pestles cat# K749521-1590. Serial dilutions were performed and 100 ul of each dilution 
plated onto 100 mm BHI gentamycin 10 ug/mL plates for 24 hours at 37˚ C.  
Tiller and Garsin 2014 
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 Table 2.1 
Name Description Marker Insert Reference 
L4440(pPD129.36)
  
Cloning vector with 
convergent T7 
polymerase 
promoters flanking 
a multiple cloning 
site (MCS). 
Ampicillin 
(Amp) 
Empty vector (TIMMONS and 
FIRE 1998) 
pGT01 L4440 backbone 
with F32A52.A 
(skpo-3a) cDNA 
Ampicillin 
(Amp) 
F32A52.A This study 
pGT02 L4440 backbone 
with F32A52.B 
(skpo-3b) cDNA 
Ampicillin 
(Amp) 
F32A52.B This study 
pGT03 L4440 backbone 
with pxn-1  cDNA 
Ampicillin 
(Amp) 
pxn-1 This study 
L4440-pxn-2* L4440 backbone 
with genomic pxn-2 
fragment 
Ampicillin 
(Amp) 
pxn-2 This study 
L4440-mlt-7* L4440 backbone 
with genomic mlt-7 
fragment 
Ampicillin 
(Amp) 
mlt-7 This study 
L4440-bli-3* L4440 backbone 
with genomic bli-3 
fragment 
Ampicillin 
(Amp) 
bli-3 This study 
L4440-C16C8.2 
(skpo-2)* 
L4440 backbone 
with genomic 
C16C8.2 fragment 
Ampicillin 
(Amp) 
C16C8.2 This study 
L4440-C46A5.4* L4440 backbone 
with genomic 
C46A5.4 fragment 
Ampicillin 
(Amp) 
C46A5.4 This study 
L4440-F09F3.5* L4440 backbone 
with genomic 
F09F3.5 fragment 
Ampicillin 
(Amp) 
F09F3.5 This study 
L4440-R08F11.7* L4440 backbone 
with genomic 
R08F11.7 fragment 
Ampicillin 
(Amp) 
RO8F11.7 This study 
L4440-F49E12.1 
(skpo-1)* 
L4440 backbone 
with genomic skpo-
1 fragment 
Ampicillin 
(Amp) 
skpo-1 This study 
L4440-K10B4.1* L4440 backbone 
with genomic 
K10B4.1 fragment 
Ampicillin 
(Amp) 
K10B4.1 This study 
L4440-T06D8.10* L4440 backbone 
with genomic 
T06D8.10 fragment 
Ampicillin 
(Amp) 
T06D8.10 This study 
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*gene names are listed according to the Ahringer C. elegans RNAi library to aid in plasmid 
identification  
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 Table 2.2 
Oligo name Purpose Sequence 
F32A52.A 5F cloning 5’ TTG CGG CCG CAA TTC ACC AGG GAA TTT 
ACA CC 3’ 
F32A52.A 3R cloning 5’ CCT CGA GGG TGG TCT TTT CAC ATT CTG G 
3’ 
F32A52.B 5F cloning 5’ TTG CGG CCG CAA CAA CCA CTC ATT TCA 
CCA GG 3’ 
F32A52.B 3R cloning 5’ CCT CGA GGC TGT AGT TGT TAC TCT TTG 
TGG 3’ 
ZK994.3 (pxn-1) 
5F 
cloning 5’ TTG CGG CCG CAA GGA CTC TGG AAG GTA 
CAC 3’ 
ZK994.3 (pxn-1) 
3R 
cloning 5’ CCT CGA GGA TAC TTG GCA CTT CCA CTC T 
3’ 
L4440 5F sequencing 5’ GTT TTC CCA GTC ACG ACG TT 3’ 
L4440 3R sequencing 5’ TGG ATA ACC GTA TTA CCG CC 3’ 
skpo-1 
transcriptional 5F 
cloning 5’ CCC AAG CTT GTC ACT ATT TCC AAA TTC 
CTT TC 3’ 
skpo-1 
transcriptional 3R 
cloning 5’ GCG TCG ACC GGT CTG AAA AAA AGT TGC 
AG 3’ 
skpo-1 
translational 5F 
cloning 5’ CGG GAT CCA TGA AGT CTC TCC TCT TCT CC 
3’ 
skpo-1 
translational 3R 
cloning 5’ GCG GTA CCG GAG GAG CTT CTC TCC AGG 
CTT CAA GGT 3’ 
F49 internal 
sequence 5F 
sequencing 5’ GTC TTA TGC CAG CTG CTT ATG AT 3’ 
F49 internal 
sequence 3R 
sequencing 5’ TTT CAG TCA CAG AAG TTG TCA AT 3’ 
F49 internal 
intergenic 5F 
sequencing 5’ CAA TTC AAT TTT TCC CTC GTT 3’ 
F49 internal 
intergenic 3R 
sequencing 5’ CCC TTA GAT GTC TAT GCT TCT 3’ 
skpo-1 pET29b 
5F (full length 
skpo-1) 
cloning 5’ GGG AAA CAT ATG AAG TCT CTC CTC TTC 
TCC 3’ 
skpo-1 pET29b 
3R 
(full length skpo-
1) 
cloning 5’ GGA AAA GGT ACC TTC TCT CCA GGC TTC 
AAG G 3’ 
skpo-1 
mutagenesis 5F 
site-directed 
mutagenesis 
5’ GTT AAC TCA CAA TTT CAA GAA GTT AAT 
AGA TAC CGG TTT ATT GAT GGA GTT A 3’ 
skpo-1 
mutagenesis 3R 
site-directed 
mutagenesis 
5’ TAA CTC CAT CAA TAA ACC GGT ATC TAT TAA 
CTT CTT GAA ATT GTG AGT TAA C 3’ 
T7 terminator 3R sequencing 5’ GCT AGT TAT TGC TCA GCG G 3’ 
RB1437 set1 
back cross 5F 
PCR 
genotyping 
5’ CTC TCA GAC GTG TTC TTT AAC 3’ 
RB1437 set1 
back cross 3R 
PCR 
genotyping 
5’ CGA CGA TAG TCA TTG TAA G 3’ 
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skpo-1 pET29b 
peroxidase 
domain only 5F  
cloning 5’  GGG AAA CAT ATG GCC CGT TTC CGG CAA 
CAA ATG 3’ 
skpo-1 pET28a 
peroxidase 
domain only 3R 
cloning 5’ GGG AAA GGA TCC CTA CTA TTC TCT CCA 
GGC 3’ 
skpo-1 Max 
Planck fosmid 5F 
sequencing 5’ CAG TTC CAT GCT CAT CGA TTA CAG GAT 
TGA ACC TTG AAG CCT GGA GAG AAG AAG TGC 
ATA CCA ATC AGG A 3’ 
skpo-1 Max 
Planck fosmid 3R 
sequencing 5’ TGG CAC TTT TAA GGA ATA CGG TGA ATG 
AGA ATG ATT GAA ACA AAT GTC TAC TTG TCG 
TCG TCA TCC TTG T 3’ 
clec-35 F qRT-PCR 5’ AGA TGC TGG ACA GTG GAA AAG 3’ 
clec-35 R qRT-PCR 5’ GTG CGG AGT ATT GTA GCG TAG 3’ 
clec-42 F qRT-PCR 5’ GTA ACT CCG TAT TGG CTG GG 3’ 
clec-42 R qRT-PCR 5’ GTA AAC GCA GCT TCC AAT CTC 3’ 
clec-60 F qRT-PCR 5’ TGT AAG AGA ACA GTT GGA ACC C 3’  
clec-60 R qRT-PCR 5’ TAT GTG CAT GGG TAC TGA TCG 3’ 
clec-71 F qRT-PCR 5’ ACG ACA GGA AGT GAT GTA TTG G 3’ 
clec-71 R qRT-PCR 5’ TTG ACG GAC TTT AGC CAC TG 3’ 
act-1 F qRT-PCR 5’ ACC ATG TAC CCA GGA ATT GC 3’ 
act-1 R qRT-PCR 5’ TGG AAG GTG GAG AGG GAA G 3’ 
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 Table 2.3 
Strains Genotype References 
Enterococcus faecalis    
OG1RF Wild type strain, FaR, RfR (DUNNY et al. 1978) 
Pseudomonas aeruginosa    
PA14 Wild type strain (RAHME et al. 1995) 
Escherichia coli    
OP50 Wild type strain, StrR (BRENNER 1974) 
HT115 Used to express dsRNA for 
RNAi in C. elegans, AmpR, 
TetR 
(GARSIN et al. 2001), 
(GARSIN et al. 2003), (KIM et 
al. 2002), (VAN DER HOEVEN 
et al. 2011) 
BL12 (DE3) Used to express pET-
29b(+) and pET-28a(+) 
(EDENS et al. 2001) 
Caenorhabditis elegans   
N2 Wild type (BRENNER 1974) 
eri-1 Enhanced RNAi strain, eri-
1(mg366) 
(KENNEDY et al. 2004) 
Hypodermal Tissue-specific RNAi strain, 
rde-1(ne129); Is[wrt-
2prom::RDE-1::unc-54 3’ 
utr; myo2p::RFP3] 
(MELO and RUVKUN 2012) 
Intestinal Tissue-specific RNAi strain, 
sid-1(qt9); Is[vha-6::sid-1] 
(MELO and RUVKUN 2012) 
RB1437 Outcrossed x 0, [skpo-
1(ok1640) II] 
This study 
skpo-1 GF89-91 RB1437 outcrossed X 5 
with N2, three independent 
lines 
This study 
 
  
40 
 
Chapter 3: SKPO-1 protects C. elegans from Enterococcus faecalis infection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The Genetics Society of America (GSA) journal of Genetics does not require me to obtain 
permission to reproduce data or text from an article in which I am an author. I have 
contributed significantly to this publication. The article is listed for reference: TILLER, G. R., 
and D. A. GARSIN, 2014 The SKPO-1 Peroxidase Functions in the Hypodermis To Protect 
Caenorhabditis elegans from Bacterial Infection. Genetics. 
41 
 
Introduction  
The peroxidase SKPO-1 (ShkT-containing peroxidase) contributes to the host 
immune response during infection with E. faecalis 
Heme-containing peroxidases play critical, wide-ranging roles in biological systems. 
Once called the “animal heme peroxidases,” members of the peroxidase-cyclooxgenase 
superfamily are actually found in all kingdoms of life (ZAMOCKY et al. 2008). The roles of 
most are poorly characterized, but some are clearly involved in immune defense. For 
example, the most famous and best-studied member of this group, myeloperoxidase 
(MPO), is found in the granulocytes of neutrophils where it catalyzes the formation of the 
potent oxidant HOCl from H2O2 and Cl- to kill invading microbes (KLEBANOFF 2005). Another 
is lactoperoxidase (LPO), which is found on mucosal surfaces and generates the protective 
oxidant hypothiocyanite (OSCN-) from H2O2 and thiocyanate (SCN-). This process is 
impaired in the lungs of cystic fibrosis (CF) patients contributing to the poor clearance of 
pathogens such as Pseudomonas aeruginosa and Staphylococcus aureus, the most 
common causes of lung infection in CF patients (CONNER et al. 2002), (FORTEZA et al. 
2005), (GEISZT et al. 2003a), (MOSKWA et al. 2007).  
 Many of these peroxidases are functionally associated with members of the NADPH 
Oxidase (NOX)/Dual Oxidase (DUOX) protein family as NOX/DUOX enzymes generate the 
H2O2 required as substrate for the peroxidases. For example, Nox2 is the source of H2O2 
for MPO. While all of the NOX/DUOX proteins produce ROS, DUOXs differ from NOXs in 
that they encode an extracellular N-terminal peroxidase domain in addition to the oxidant-
generating NADPH oxidase domain, which is located at the C-terminus (RADA et al. 2008), 
(SUMIMOTO 2008). Intriguingly while DUOXs possess a peroxidase domain, these proteins 
appear to still associate with separate peroxidases. For example, LPO utilizes H2O2 
generated by Duox1 or Duox2 (CONNER et al. 2002), (FORTEZA et al. 2005), (GEISZT et al. 
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2003a). In fact, the peroxidase domains of human Duox1/2 are reported to lack peroxidase 
activity and may have other functions, such as serving as an interaction domain for 
separate, active peroxidases (MEITZLER et al. 2013), (MEITZLER and ORTIZ DE MONTELLANO 
2009), (MEITZLER and ORTIZ DE MONTELLANO 2011).  
 The host’s production of ROS is an ancient, evolutionarily conserved defense 
mechanism and C. elegans has been used as a model host to study various aspects of the 
innate immune response including the purposeful generation of reactive oxygen species 
(ROS) during infection (CHAVEZ et al. 2007), (CHAVEZ et al. 2009). The animal encodes only 
one functional NADPH oxidase, a dual oxidase called BLI-3 and when exposed to human 
pathogens such as the Gram-positive, opportunistic bacterium, Enterococcus faecalis, H2O2 
is released (CHAVEZ et al. 2007), (EDENS et al. 2001). The production of H2O2 in response 
to infection appears protective, as its loss by reducing the expression of bli-3 by RNAi (RNA 
interference) renders the animals more sensitive to killing by the pathogen (CHAVEZ et al. 
2009). Using indirect immunofluorescence, BLI-3 was localized to the hypodermis, which is 
essentially the “skin” of C. elegans (EDENS et al. 2001). Additionally, there is speculation 
that BLI-3 may be present in the intestinal cells (CHAVEZ et al. 2007), (CHAVEZ et al. 2009).  
In addition to playing a role in innate immunity, BLI-3 is essential to the normal 
development of the worm because it contributes to the generation of the tyrosine-linked 
collagen necessary for proper biogenesis of the cuticle, i.e. the exoskeleton of the animal. 
Its role appears two-fold. First, BLI-3 generates the necessary substrate, H2O2, by its NOX 
domain. Second, BLI-3 uses its N-terminal peroxidase domain and oxidizes the tyrosines of 
the collagen proteins to tyrosyl radicals that then combine to form di- and tri-tyrosines, 
thereby cross-linking the cuticle (EDENS et al. 2001). Unlike human Duox1/2, the peroxidase 
domain of BLI-3 has low levels of peroxidase activity that is essential to this process, and 
mutations in the peroxidase domain that disrupt this activity results in a “blistered” (bli) 
phenotype (BRENNER 1974), (MEITZLER and ORTIZ DE MONTELLANO 2009), (MEITZLER et al. 
43 
 
2010), (MEITZLER and ORTIZ DE MONTELLANO 2011), (SIMMER et al. 2003). Interestingly, 
recent work has demonstrated that the peroxidase domain of BLI-3 is not the only 
peroxidase involved in this process. A separate peroxidase, MLT-7, contributes to cuticle 
cross-linking and loss of this activity results in the same bli phenotype as loss of the BLI-3 
peroxidase domain.  Additionally, loss of both peroxidase activities greatly increases the 
severity of cuticle blistering (THEIN et al. 2009). 
 Because of the prevalent functional association of NOX/DUOX proteins with 
peroxidases in immune responses, we hypothesized that C. elegans might also utilize a 
peroxidase(s) in host defense, perhaps in conjunction with its NADPH oxidase, BLI-3. In 
support of this hypothesis, during an earlier investigation by our laboratory, it was 
determined that the peroxidase domain of BLI-3 is not involved in the immune response, as 
point mutants in this domain had wild type resistance to E. faecalis, despite their blistered 
phenotype (CHAVEZ et al. 2009). 
         Tiller and Garsin 2014 
Thus is stands to reason that either the NADPH oxidase domain of BLI-3 is 
sufficient to provide protection during infection or that an unknown peroxidase is functionally 
associating with BLI-3 to contribute to the host’s defense. 
 
Results 
Host resistance to E. faecalis is affected by skpo-1 
To investigate if C. elegans possesses any peroxidases involved in host defense, I 
utilized an RNAi-killing assay to screen candidate peroxidase genes. The candidate genes 
were found using the BLI-3 peroxidase domain as the BLAST query on WormBase.org. 
Twelve putative peroxidase-encoding genes were identified, nine of which were available in 
the RNAi library (FRASER et al. 2000), (KAMATH et al. 2003), including the previously studied 
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mlt-7 (THEIN et al. 2009). Standard molecular biology techniques were used to generate the 
three missing RNAi constructs (Materials and Methods). Using a background in which RNAi 
efficiency is increased (eri-1) (KENNEDY et al. 2004), the expression of these genes was 
reduced in C. elegans. The animals were then exposed to E. faecalis and survival was 
scored over time. By these means, the genes were screened for possible roles in innate 
immune function. The reduced expression of three genes—F09F3.5, R08F11.7, and 
F49E12.1—resulted in a statistically significant susceptibility phenotype (Table 3.1). I 
decided to focus on F49E12.1, as it possessed high homology to human myeloperoxidase 
(hMPO, 34% sequence identity) and a deletion mutant was available through the CGC 
(Caenorhabditis Genetics Center). As described in more detail below, the predicted protein 
associated with this gene contains an N-terminal metridin Shk toxin (ShkT)-like domain and 
a C-terminal peroxidase domain and was therefore named SKPO-1 for ShkT-containing 
peroxidase. 
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Table 3.1 Susceptibility to E. faecalis following RNAi of putative peroxidase genes 
 
 
 
Tiller and Garsin 2014 
  
RNAi Treatment Susceptibility Phenotype Median 
survival (days) 
P-value 
mlt-7 
control 
Wild type 6 
6 
0.3070 
pxn-1 
control 
Wild type 4 
4 
0.9218 
pxn-2 
control 
Wild type 6 
6 
0.8233 
C16C8.2 
control 
Wild type 9 
9 
0.1067 
C46A5.4 
control 
Wild type 10 
10 
0.7206 
F09F3.5 
control 
susceptible 6 
7 
0.0058 
F32A5.2a 
control 
Wild type 5 
5 
0.2499 
F32A5.2b 
control 
Wild type 6 
6 
0.4115 
F49E12.1 (skpo-1) 
control 
susceptible 5 
9 
0.0053 
R08F11.7 
Control 
susceptible 6 
7 
0.0004 
K10B4.1 
Control 
Wild type 8 
8 
0.7904 
T06D8.10 
Control 
Wild type 8 
8 
0.6636 
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An example of the survival of skpo-1 RNAi eri-1 mutant animals on E. faecalis 
compared to vector control (VC) RNAi eri-1 mutant animals is shown in Figure 3.1A. skpo-1 
RNAi animals displayed an enhanced susceptibility phenotype relative to VC RNAi (P = 
0.0011). The experiment was repeated five times and the data was tabulated in Table 3.2. I 
also examined the lifespan of these animals to see if skpo-1 RNAi caused a general fitness 
defect. However, on E. coli OP50, lifespan of the skpo-1 RNAi animals was not significantly 
different when compared to VC RNAi animals (P = 0.3772) (Figure 3.1B and Table 3.3).   
To further examine the phenotype resulting from the loss of skpo-1, I obtained the 
partial deletion strain, RB1437 from the CGC. The deletion is between bases 827 and 3,202 
of the 5,008 full-length transcript, which ablates a significant portion of the protein, including 
the critical amino acid residues necessary for peroxidase activity in classical animal heme 
peroxidases (Figure 3.2) (ORTIZ DE MONTELLANO 2008). Strain RB1437 was backcrossed 
five times into our wild type N2 strain and three lines were generated GF89, GF90 and 
GF91. As shown in Figure 3.3, these animals were very susceptible to E. faecalis compared 
to wild type N2 animals. Also, as significant differences in susceptibility were not observed 
between the strains, I continued the studies using GF89, which will be referred to as skpo-
1.   
Interestingly, I observed a significant “bagging” phenotype—hatching of embryos 
inside the hermaphrodite that had failed to be expelled—when the skpo-1 mutant animals 
were exposed to E. faecalis, unlike the skpo-1 RNAi animals. It has been postulated that a 
bagging phenotype in response to infection may result in an enhanced susceptibility 
phenotype that is an artefact. The opposite side of the argument is that in response to 
infection, a bagging phenotype provides protection for the developing larvae as well as 
nutrition.  
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Figure 3.1 SKPO-1 contributes to C. elegans resistance to E. faecalis. (A) Survival of 
eri-1 mutant worms on E. faecalis OG1RF following exposure to vector control (VC) RNAi 
and skpo-1 RNAi (P = 0.0011). (B) Longevity of eri-1 mutant worms on E. coli OP50 
following exposure to VC RNAi, and skpo-1 RNAi (P = 0.3772). (C) Survival of wild type 
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and skpo-1 mutant worms on E. faecalis following exposure to cdc-25.1 RNAi (P < 0.0001). 
(D) Longevity of wild type and skpo-1 mutant worms on E. coli OP50 following exposure to 
cdc-25.1 RNAi (P < 0.0001). (E) The relative mortality of skpo-1 mutant worms exposed to 
E. faecalis (EF) is expressed as a ratio of (LT50 of wild type cdc-25.1 RNAi on EF/LT50 of 
skpo-1 mutant cdc-25.1 RNAi on EF) over (LT50 of wild type cdc-25.1 RNAi on E. coli/LT50 
of skpo-1 mutant cdc-25.1 RNAi on E. coli). The average of four, independent experiments, 
with 90 animals each, was used to calculate the relative mortality. (F) Survival of wild type 
and skpo-1 mutant worms on P. aeruginosa following exposure to cdc-25.1 RNAi (P = 
0.3783). Error bars represent standard error of the mean (S.E.M.) and the asterisk indicates 
a significant difference between wild type and skpo-1 mutant worms (P = 0.0091). The P-
values were calculated using Student’s paired t-test. The median survival for survival and 
longevity assays are listed in Tables 3.2 and 3.3 along with replicates of the experiments. 
         Tiller and Garsin 2014 
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Table 3.2   Median survival and P-values of E. faecalis OG1RF killing assays 
Figure 
number 
Experiment 
number 
Strain, exposure conditions 
during development 
Median 
survival 
(days) 
P-value 
3.1A 1 wild type, VC RNAi 
wild type, skpo-1 RNAi 
8 
7 
C 
=0.0404 
 2 wild type, VC RNAi 
wild type, skpo-1 RNAi 
7 
6 
C 
=0.0331 
 3 eri-1, VC RNAi 
eri-1, skpo-1 RNAi 
8 
7 
C 
=0.001 
 4 eri-1, VC RNAi 
eri-1, skpo-1 RNAi 
7 
5 
C 
=0.0053 
 5 eri-1, VC RNAi 
eri-1, skpo-1 RNAi 
9 
8 
C 
=0.0037 
3.1C 1 wild type, cdc-25.1 RNAi 
skpo-1, cdc-25.1 RNAi 
10 
6 
C 
<0.0001 
 2 wild type, cdc-25.1 RNAi 
skpo-1, cdc-25.1 RNAi 
10 
8 
C 
<0.0001 
 3 wild type, cdc-25.1 RNAi 
skpo-1, cdc-25.1 RNAi 
13 
8 
C 
=0.0016 
 4 wild type, cdc-25.1 RNAi 
skpo-1, cdc-25.1 RNAi 
13 
8 
C 
=0.0005 
 5 wild type, cdc-25.1 RNAi 
skpo-1, cdc-25.1 RNAi 
13 
7 
C 
<0.0001 
3.10A 1 wrt-2, VC RNAi 
wrt-2, skpo-1 RNAi 
5 
4 
C 
=0.0002 
 2 wrt-2, VC RNAi 
wrt-2, skpo-1 RNAi 
4 
3 
C 
=0.0176 
 3 wrt-2, VC RNAi 
wrt-2, skpo-1 RNAi 
5 
4 
C 
=0.0376 
 4 wrt-2, VC RNAi 
wrt-2, skpo-1 RNAi 
4 
4 
C 
=0.0058 
3.10C 1 vha-6, VC RNAi 
vha-6, skpo-1 RNAi 
11 
11 
C 
=0.6379 
 2 vha-6, VC RNAi 
vha-6, skpo-1 RNAi 
11 
11 
C 
=0.735 
3.3 1 wild type, OP50 
skpo-1*, OP50 
8 
3 
C 
<0.0001 
 2 wild type, OP50 
skpo-1*, OP50 
8 
3 
C 
<0.0001 
C = control, *Data only shown for GF89 skpo-1 strain. 
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Table 3.3   Median survival and P-values of E. coli OP50 longevity assays 
Figure 
number 
Experiment 
number 
Strain, exposure conditions 
during development 
Median 
survival 
(Days) 
P-value 
3.1B 1 eri-1, VC RNAi 
eri-1, skpo-1 RNAi 
10 
10 
C 
=0.3772 
 2 eri-1, VC RNAi 
eri-1, skpo-1 RNAi 
10 
10 
C 
=0.8948 
3.1D 1 wild type, cdc-25.1 RNAi 
skpo-1, cdc-25.1 RNAi 
10 
8 
C 
<0.0001 
 2 wild type, cdc-25.1 RNAi 
skpo-1, cdc-25.1 RNAi 
14 
11 
C 
<0.0001 
 3 wild type, cdc-25.1 RNAi 
skpo-1, cdc-25.1 RNAi 
14 
11 
C 
<0.0001 
3.10B 1 vha-6, VC RNAi 
vha-6, skpo-1 RNAi 
10 
10 
C 
=0.9997 
 2 vha-6, VC RNAi 
vha-6, skpo-1 RNAi 
11 
10 
C 
=0.4484 
3.10D 1 wrt-2, VC RNAi 
wrt-2, skpo-1 RNAi 
11 
11 
C 
=0.6379 
 2 wrt-2, VC RNAi 
wrt-2, skpo-1 RNAi 
11 
11 
C 
=0.7235 
3.4 1 wild type, OP50 
skpo-1, OP50 
14 
11 
C 
<0.0001 
 2 wild type, OP50 
skpo-1, OP50 
14 
11 
C 
<0.0001 
3.5* 1 N2, cdc-25.1 RNAi* 
skpo-1, cdc-25.1 RNAi* 
16 
13 
C 
<0.0001 
 2 N2, cdc-25.1 RNAi* 
skpo-1, cdc-25.1 RNAi* 
14 
12 
C 
<0.0001 
C = control, *Assayed on heat-killed OP50     
Tiller and Garsin 2014 
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Figure 3.2 Wild type and mutant SKPO-1 protein domain cartoon. Cartoon depiction of 
the protein domains in both the wild type (Top) and mutant (Bot.) SKPO-1 protein. Red line 
indicates the amino acids (141 through 510) deleted as a result of EMS mutagenesis due to 
the host’s double-stranded DNA break repair mechanism (unpublished). 
  
52 
 
 
Figure 3.3 Survival of cdc-25.1 RNAi-treated skpo-1 mutant animal lines on E. 
faecalis. Wild type and skpo-1 mutant worms were grown on cdc-25.1 dsRNA expressing 
E. coli HT115 from L1 through L4 larval stage prior to exposure to E. faecalis OG1RF. The 
skpo-1 mutant worms (GF89, GF90 and GF91) were more susceptible to E. faecalis relative 
to wild type (P-values < 0.0001, 0.0110, and < 0.0001, respectively).  
         Tiller and Garsin 2014 
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As I was concerned that this “bagging” was artificially enhancing their sensitivity to 
E. faecalis, thus cdc-25.1 RNAi was employed to induce sterility, as done in previous C. 
elegans pathogenesis studies (IRAZOQUI et al. 2008), (SHAPIRA et al. 2006), (VAN DER 
HOEVEN et al. 2011) (Figure 3.1 C-E). skpo-1 mutant animals grown on cdc-25.1 dsRNA-
expressing E. coli HT115 did not display this maternal bagging phenotype when they were 
subsequently exposed to E. faecalis. cdc-25.1 RNAi-exposed skpo-1 mutant worms 
retained a more pronounced susceptibility phenotype to E. faecalis relative to similarly 
exposed wild type animals (P < 0.0001) (Figure 3.1C and Table 3.2). This result suggests 
that the pathogen sensitivity is not explained by a maternal bagging phenotype.  
Regardless of whether skpo-1 mutant worms were sterile, i.e. cdc-25.1-treated 
(Figure 3.1D and Table 3.3), or fecund (Figure 3.4 and Table 3.3), they displayed a slight 
reduction in lifespan, relative to wild type, when exposed to live E. coli OP50 (P < 0.0001, 
for both). Because live OP50 has been shown to have slightly pathogenic effects (GARIGAN 
et al. 2002), I also examined lifespan on heat-killed OP50 and found that cdc-25.1 RNAi-
exposed skpo-1 mutant worms still displayed a reduction in lifespan (Figure 3.5 and Table 
3.3). To determine if the reduction in lifespan completely accounted for the pathogen 
sensitivity or not, the relative mortality of skpo-1 mutant worms, compared to wild type, was 
calculated as in previous work (CHAVEZ et al. 2007), (TENOR et al. 2004). Relative mortality 
is the ratio of the LT50 of pathogen-infected animals to uninfected animals with the ratio of 
wild type animals normalized to one and has been used in previous work to analyze 
susceptibility phenotypes (CHAVEZ et al. 2007; TENOR et al. 2004). The survival defect for 
the skpo-1 mutant animals on E. faecalis was more severe than on non-pathogenic E. coli 
compared to wild type animals (P = 0.0091) (Figure 3.1E and Table 3.4). These data argue 
against the general fitness defect fully explaining the susceptibility phenotype to E. faecalis.  
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To further examine the extent of the susceptibility-to-pathogen phenotype and 
determine if it was pathogen specific, I used P. aeruginosa instead of E. faecalis in the 
killing assay (P = 0.3783) (Figure 3.1F and Table 3.5). I observed no significant difference 
in survival between cdc-25.1 RNAi skpo-1 mutants and cdc-25.1 RNAi wild type animals 
when exposed to P. aeruginosa. These results suggest that the function of SKPO-1 may be 
beneficial during infection with some, but not all pathogens. 
Tiller and Garsin 2014 
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Figure 3.4 Lifespan defect of skpo-1 mutants on E. coli OP50 without prior cdc-25.1 
exposure. Wild type and skpo-1 mutant worms were grown on E. coli OP50 from L1 
through L4 larval stage prior to the longevity assay in which they were transferred to NGM 
plates with FUDR (100 µg/ml) seeded with concentrated (20X) E. coli OP50. The average 
lifespan of the skpo-1 mutant worms was significantly shorter than their wild type, 
counterparts (P-value < 0.0001). 
         Tiller and Garsin 2014 
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Figure 3.5 skpo-1 mutants display a lifespan defect on heat-killed E. coli OP50. Wild 
type and skpo-1 mutant worms were grown on cdc-25.1 dsRNA expressing E. coli HT115 
from L1 through L4 larval stage prior to the longevity assay. The worms were transferred to 
NGM plates like in Figure 3.4; however, the E. coli OP50 had been heat-killed. We 
observed that the skpo-1 mutant worms displayed a longevity defect on heat-killed OP50, 
relative to wild type worms (P-value <0.0001). 
        Tiller and Garsin 2014 
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Table 3.4   Data for Relative Mortality Calculation  
Figure number Experiment 
number 
Strain Relative 
mortality 
P-value 
3.1E Average of 
experiments 
1-4 
N2 
 
 
 
 
skpo-1 
1 
1 
1 
1 
Avg = 1 
1.312 
1.452 
1.654 
1.253 
Avg = 1.418 
 
 
 
 
C 
 
 
 
 
=0.0091 
C = control 
         Tiller and Garsin 2014 
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Table 3.5   Median survival and P-values of P. aeruginosa PA14 killing assays 
Figure Number Experiment 
number 
Strain, exposure 
conditions during 
development 
Median 
survival 
(Hours) 
P-value 
3.1F 1 N2, cdc-25.1 RNAi 
skpo-1, cdc-25.1 RNAi 
91 
88 
C 
=0.3783 
 2 N2, cdc-25.1 RNAi 
skpo-1, cdc-25.1 RNAi 
89 
69 
C 
=0.0639 
 3 N2, cdc-25.1 RNAi 
skpo-1, cdc-25.1 RNAi 
72 
72 
C 
=0.2613 
C = control 
Tiller and Garsin 2014 
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To determine if the susceptibility phenotype on E. faecalis was a result of changes 
in pathogen burden, I assessed how many colony-forming units (CFUs) were in the 
intestines of the infected worms. Wild type and skpo-1 mutant animals were raised on E. 
coli OP50 until L4 and then exposed to E. faecalis for 12 or 36 hours. The infected worms 
were washed, to remove surface bacteria, homogenized, and then serial dilutions of the 
homogenates were spread onto Gentamycin-containing BHI plates (thus killing E. coli 
OP50) and incubated 37˚ C. I observed no significant difference in CFUs per worm between 
the wild type and skpo-1 mutant animals at either time point (Figure 3.6). The result 
suggests that the susceptibility phenotype of the skpo-1 mutant cannot be explained by an 
increased load of bacteria in the intestine. 
To test for alterations in the immune response between the skpo-1 mutant and wild 
type animals a small panel of genes known to be upregulated in response to E. faecalis 
were examined, clec-35, 42, 60, and 71. These genes encode C-type lectins (clec), many of 
which are upregulated in response to pathogens (DIERKING et al. 2011), (IRAZOQUI et al. 
2010a). I investigated if these genes were differentially regulated in the skpo-1 mutant, 
which could be indicative of an altered immune response. Sterile (by exposure to cdc-25.1 
RNAi) wild type and skpo-1 mutant animals at the L4 stage were exposed to E. faecalis or 
E. coli for 18 hours, at which point the animals were lysed and RNA was extracted. By qRT-
PCR no significant difference in fold induction for any of the clec genes was observed 
between the wild type and skpo-1 mutants exposed to E. faecalis (Figure 3.7).Thus, loss of 
skpo-1 does not significantly affect fold induction of the clec genes tested.   
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Figure 3.6   The skpo-1 mutant does not have increased intestinal bacterial load 
during E. faecalis infection. L4 wild type and skpo-1 mutant animals were exposed to E. 
faecalis at 25˚ C for 12 or 36 hours, respectively. CFU values for both wild type and skpo-1 
mutant animals indicated that there is no significant difference in intestinal colonization by 
E. faecalis. Three biological replicates for each strain were used per time point and the 
experiment repeated twice—i.e a total n = 60 per strain. The graph is an average of the two 
independent experiments. P-values were 0.3913 and 0.3592 for 12 and 36 hours, 
respectively. 
         Tiller and Garsin 2014 
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Figure 3.7   Fold induction of selected clec genes are not significantly altered in 
skpo-1 mutants. L4 wild type and skpo-1 mutant animals were exposed to E. faecalis for 
18 hours at 25˚ C. Three technical replicates per strain per gene were assayed for relative 
expression of innate immune response genes and the experiment was repeated, 
independently, twice. The graph represents the average of the two independent 
experiments. These genes were previously found to display increased expression in wild 
type animals in response to E. faecalis (WONG et al. 2007). None of the clec genes assayed 
displayed altered fold induction in (un)infected skpo-1 mutants relative to N2 animals. clec 
gene expression was normalized to act-1. P-values were 0.2203, 0.1868, 0.1396, and 
0.4828  for clec-35, 42, 60 and 71, respectively (unpublished). 
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Morphological characterization of skpo-1 mutant animals 
Animals deficient in the peroxidase mlt-7 displayed altered morphology, including a 
bli (blistered) phenotype, indicative of incomplete cross-linking of the cuticle (THEIN et al. 
2009). The phenotype strongly suggests that MLT-7’s peroxidase activity contributes to 
cuticle formation (THEIN et al. 2009). Interestingly, despite this rather dramatic cuticle 
defect, an increase in susceptibility to E. faecalis was not observed (Table 3.1). To 
determine if SKPO-1 is also involved in cuticle biogenesis I observed the morphology of 
skpo-1 RNAi and mutant animals. RNAi of skpo-1 did not result in any visible morphological 
change in the eri-1 mutant animals (Figure 3.8B). However, the skpo-1 mutant did display 
some morphological phenotypes. I observed young adult animals under the dissecting 
microscope (N = 300) and found that they ranged from very dumpy (16%), to slightly dumpy 
(33%), to wild type (51%) in appearance (Figure 3.8C – E). This dpy phenotype range is 
apparent from L1 onwards. Interestingly, regardless of the hermaphrodite parent’s 
morphotype that sired the brood, I observed the aforementioned ratio of very dumpy, 
slightly dumpy and wild type in its progeny—which suggests incomplete penetrance. 
Additionally, no blistering of the cuticle was ever observed. Because a dumpy phenotype 
can be associated with cuticle defects (THEIN et al. 2009), these results suggest that SKPO-
1 may have some role in cuticle biogenesis, but one that is different than MLT-7. 
Tiller and Garsin 2014 
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Figure 3.8 skpo-1 mutant morphology suggests incomplete penetrance. (A) Wild type 
young adult representing the approximate average size and morphology of a typical C. 
elegans. (B) skpo-1 RNAi young adult raised on skpo-1 dsRNA expressing E. coli HT115 
from L1 through L4 stage. (C – E) Young adult skpo-1 mutants ranged from very dumpy to 
wild type in size. 10X microscopy images are representative of >100 wild type, skpo-1 RNAi 
and skpo-1 mutant worms observed, respectively. 
         Tiller and Garsin 2014 
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SKPO-1 features and activity  
As mentioned, SKPO-1 contains a ShkT-like domain at its N-terminus from 
approximately residues 21 to 56 (www.WormBase.org) in addition to the predicted 
peroxidase domain (Figure 3.9A). It shares this feature with MLT-7 (THEIN et al. 2009), and 
putative peroxidases C16C8.2 and F32A5.2 (Table 3.1). For this reason I propose naming 
F49E12.1, SKPO-1, and C16C8.2 and F32A5.2, SKPO-2 and SKPO-3 for ShkT-containing 
peroxidase. In addition to the ShkT-like domain, the very 5’ end contains a predicted signal 
sequence for secretion, and cleavage is predicted to occur at Ser19 (www.predisi.de).  
To examine SKPO-1’s peroxidase domain, I aligned it with other well-characterized 
peroxidase domains-of-interest, specifically those contained in hMPO, BLI-3 and MLT-7. 
Upon alignment, I observed SKPO-1 possesses the catalytic triad (distal histidine, H222; 
arginine, R332; and proximal histidine, H428) necessary for peroxidase activity (ORTIZ DE 
MONTELLANO 2008). However, SKPO-1 lacks the residues necessary for covalent heme-
binding, characteristic of the animal heme peroxidase family (ORTIZ DE MONTELLANO 2008). 
Interestingly, human Duox1/2 (hDuox1/2) also lack the conserved aspartic and glutamic 
residues required for covalent linkage of the heme prosthetic group; however, both of these 
recombinant peroxidase domains still bind heme, albeit weakly (MEITZLER and ORTIZ DE 
MONTELLANO 2009; MEITZLER and ORTIZ DE MONTELLANO 2011). This non-covalent binding 
may explain MLT-7’s peroxidase activity even though MLT-7 lacks these covalent heme-
binding residues (THEIN et al. 2009).  
By comparison, SKPO-1 possesses all of the highlighted residues in MLT-7 (Figure 
3.9A) and shares significant identity with hMPO (34% identity). Thus, I decided to indirectly 
assay SKPO-1’s potential peroxidase activity using an Amplex Red assay, modified for 
whole animals, that detects H2O2 (CHAVEZ et al. 2007), (CHAVEZ et al. 2009). Previously, 
our laboratory observed that exposure to E. faecalis causes a significant release in H2O2 
dependent on the NADPH oxidase, BLI-3 (CHAVEZ et al. 2007), (CHAVEZ et al. 2009). Thus, 
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I reasoned that loss of an important peroxidase during this release might increase the 
amount of H2O2 detected. After infecting VC and skpo-1 RNAi eri-1 mutant animals with E. 
faecalis for twelve hours, released H2O2 was measured (Figure 3.9B). As hypothesized, 
skpo-1 RNAi eri-1 mutant animals released significantly greater (P = 0.0091) amounts of 
H2O2, relative to VC RNAi eri-1 mutants, consistent with the loss of a predicted H2O2 sink. 
The same result was observed with the skpo-1 mutants compared to wild type animals (P 
<0.0001) (Figure 3.9C). The difference in H2O2 detected required E. faecalis, and the 
concomitant release of H2O2, as no significant differences were observed between wild type 
and skpo-1 deficient animals on E. coli (Figures 3.9B and 3.9C).  
As mentioned earlier our laboratory previously observed that BLI-3 was necessary 
for the increase in H2O2 levels in response to infection by using the Amplex Red assay in 
conjunction with a NADPH oxidase inhibitor (CHAVEZ et al. 2007). Also, our laboratory 
demonstrated, previously, that BLI-3 is the only expressed NADPH oxidase encoded by the 
genome (CHAVEZ et al. 2009), and diphenyleneiodonium chloride (DPI) can be utilized to 
reduce its activity in wild type animals (CHAVEZ et al. 2007). Therefore to determine if the 
increased amount of H2O2 produced by the skpo-1 mutant during infection was dependent 
on BLI-3 activity, I added the NADPH oxidase inhibitor, DPI, to the assay. As seen in Figure 
3.9C, DPI abrogated the enhanced H2O2 generation observed in skpo-1 mutant animals. 
Taken together, Figure 3.9 supports my hypothesis that SKPO-1 is a peroxidase that 
utilizes H2O2 produced by BLI-3 during infection. Additionally, my attempts to purify the 
protein to demonstrate definitive peroxidase activity in vitro were not successful and will be 
discussed in Chapter 4. 
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Figure 3.9 Evidence that skpo-1 is a potential peroxidase. (A) Peroxidase domain 
sequences were aligned against the putative peroxidase domain of SKPO-1. SKPO-1 
possesses the distal histidine (H222), catalytic arginine (R332), and proximal histidine (H428), 
which are necessary for peroxidase activity. However, SKPO-1 lacks covalent heme-
binding residues (S221 and L335) that are characteristic of mammalian peroxidases (ORTIZ DE 
MONTELLANO 2008). (B) eri-1 mutant worms were grown on VC RNAi or skpo-1 RNAi prior 
to exposure with either E. coli or E. faecalis for twelve hours at 25˚C. (C) Wild type and 
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skpo-1 mutant worms were grown on cdc-25.1 RNAi prior to exposure with either E. coli or 
E. faecalis for twelve hours at 25˚C. (B-C) Following exposure to E. coli or E. faecalis the 
amount of H2O2 produced per minute was determined using the Amplex Red assay. Error 
bars represent the S.E.M. and the asterisks indicate significant differences between eri-1 
worms exposed to VC RNAi or skpo-1 RNAi that were infected with E. faecalis as well as 
between wild type and skpo-1 mutant worms exposed to cdc-25.1 RNAi prior to infection 
with E. faecalis [P = 0.0091 and P = <0.0001 (B) and (C), respectively]. Additionally, wild 
type and skpo-1 mutant worms were exposed to 80 uM DPI (diphenyleneiodinium chloride) 
and H2O2 levels were calculated for both E. coli and E. faecalis exposed animals (E.C.: P = 
0.0752; E.F.: P = 0.4161, respectively) P-values were calculated via Student’s paired t-test. 
Data in (B) and (C) are representative of at least two independent replicates. 
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SKPO-1 localizes to the hypodermis 
 In the wild, C. elegans is found both in the soil and on fruits, therefore its cuticle is in 
constant contact with its surrounding environment which includes nonpathogenic and 
pathogenic microbes. In the laboratory setting, C. elegans interfaces with E. faecalis at the 
cuticle, synthesized by the underlying hypodermis, as it crawls through the pathogen lawn, 
and in its intestine, due to ingestion of the bacteria (GARSIN et al. 2001). It has previously 
been demonstrated that C. elegans mounts immune responses at these host-pathogen 
boundaries. Additionally, these immune responses depend on the pathogen and the nature 
of the infection (IRAZOQUI et al. 2010a), (PUJOL et al. 2008), (WONG et al. 2007). To address 
what tissue SKPO-1’s activity is required for normal levels of resistance to E. faecalis, a 
tissue-specific RNAi approach was employed. RNAi-defective strains of C. elegans were 
used in which RNAi activity was genetically restored to specific tissues through intestinal or 
hypodermal specific promoters (vha-6::SID-1 and wrt-2::RDE-1, respectively) (MELO and 
RUVKUN 2012). In Figures 3.10A and 3.10C (and Table 3.2), I tested the susceptibility of the 
hypodermal and intestinal-specific RNAi strains to E. faecalis. 
As in Figure 3.1, these strains were exposed to VC and skpo-1 RNAi prior to 
infection. In the hypodermal RNAi strain, I observed an enhanced susceptibility phenotype 
to E. faecalis in the skpo-1 RNAi animals relative to VC RNAi (P = 0.0002); however, in the 
intestinal RNAi strain, no significant difference between skpo-1 and VC RNAi animals was 
observed when on E. faecalis (P = 0.9435). On E. coli, no significant difference was 
observed between VC and skpo-1 RNAi for either the hypodermal or intestinal RNAi line (P 
= 0.9997 and P = 0.6379; Figure 3.10B and 3.10D, respectively and Table 3.3). From these 
experiments I conclude that SKPO-1’s functional activity during pathogen exposure is 
required in the C. elegans hypodermis. 
To determine in which tissue SKPO-1 is produced, I used indirect 
immunofluorescence to visualize SKPO-1 localization in young adult animals raised under 
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standard conditions. The reason for using young adult animals is that L4 or young adults 
are typically used to study infectious processes. Using rabbits, a polyclonal primary 
antibody was raised against a chemically synthesized SKPO-1 peptide (see Materials & 
Methods). A freeze-cracking methodology was used to disrupt the cuticle of the animal and 
allow for internal fixation and staining (SEYDOUX and DUNN 1997). Following fixation, the 
samples were double stained with the polyclonal primary antibody to SKPO-1 and an Alexa 
Fluor 488 secondary antibody. Localization was clearly observed in the hypodermis of wild 
type animals, and an example is shown in Figure 3.11 (A-C and D-F; 40X and 10X, 
respectively). I observed strong fluorescent staining just under the outermost layer, which 
corresponds to the hypodermis. No internal organs showed evidence of staining, including 
the gonad and the intestine, which in this animal had become partially separated from the 
rest of the body. In contrast to wild type, skpo-1 mutant animals showed no evidence of 
staining in any organ (Figure 3.11G-I).  
By using a secondary antibody conjugated to 10 nm gold particles for immuno-gold 
labeling, we examined localization at higher resolution by transmission electron microscopy 
(TEM). As seen in Figure 3.11J, the black dots, indicating the gold particles, were located 
just under the cuticle layer in association with the hypodermal cells of wild type animals.  
Hardly any particles were observed in the skpo-1 mutant animals (Figure 3.11K).  The few 
observed, were randomly scattered. In total, these results demonstrate SKPO-1 is both 
physically present and functionally active in the C. elegans hypodermis. 
         Tiller and Garsin 2014 
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Figure 3.10 SKPO-1 is necessary in the hypodermis for resistance to E. faecalis 
infection. (A) Survival of the hypodermal RNAi strain on E. faecalis following exposure to 
VC RNAi or skpo-1 RNAi (P = 0.0002). (B) Longevity assay on E. coli OP50 of the 
hypodermal RNAi strain following exposure to VC RNAi or skpo-1 RNAi (P = 0.9997). (C) 
Survival of the intestinal RNAi strain on E. faecalis following exposure to VC RNAi or skpo-1 
RNAi (P = 0.9435). (D) Longevity assay of the intestinal RNAi strain on E. coli OP50 
following exposure to VC RNAi or skpo-1 RNAi (P = 0.6379).  
         Tiller and Garsin 2014 
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Figure 3.11 SKPO-1 localizes to the C. elegans hypodermis. (A-F, J) Wild type and (G-I, 
K) skpo-1 mutant worms were immunostained with anti-SKPO-1 polyclonal antibodies and 
imaged using fluorescence (A-I) or transmission electron microscopy (J-K), respectively. (A-
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C) 40X magnification of a wild type worm shows hypodermal SKPO-1 localization. (D-F) 
10X magnification of a wild type worm. (G-I) 10X magnification of skpo-1 mutant worm 
shows loss of SKPO-1 staining. (J) In wild type worms, the black dots, indicative of 
immuno-gold labeling, are localized beneath the cuticle layer, but external to the outer 
hypodermal cell surface. (K) In skpo-1 mutant worms, very few black dots are observed. 
White arrowhead = apical hypodermal surface; black arrowhead = 10 nm gold-labeled 
secondary to SKPO-1). Microscopy images are representative of >100 (fluorescent) or >10 
(TEM) wild type and skpo-1 mutant worms observed.  The TEM was performed by Steve 
Kolodziej. 
         Tiller and Garsin 2014 
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Figure 3.12 Immunoblot demonstrates SKPO-1 is absent in skpo-1 mutant animals. 
L4 wild type and skpo-1 mutant animals (grown on E. coli OP50 from eggs) were exposed 
to E. coli for 18 hours at 25˚ C prior to sonication. SKPO-1 was observed to between 75-
100 kDa which is suggestive of post-translational modification as SKPO-1 is predicted to be 
655 a.a. Black bar denotes that the lanes were cropped together from the same 
immunoblot. Immunoblot is representative of three independent biological replicates 
(unpublished data). 
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Figure 3.13 SKPO-1 hypodermal localization pattern is independent of infection. L4 
wild type animals were exposed to E. coli or E. faecalis for 24 hours at 25˚ C and then 
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immunostained with anti-SKPO-1 to determine if SKPO-1’s localization changes in 
response to infection. (A-C) Wild type animals exposed to E. coli displayed hypodermal 
localization of SKPO-1. (D-F) Wild type animals exposed to E. faecalis also revealed 
SKPO-1 to only localize to the hypodermis. All images are at 20X magnification. Microscopy 
images are representative of >100 fluorescent wild type worms observed (unpublished 
data). 
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To confirm that the ɑ-SKPO-1 polyclonal antibody was specific to SKPO-1, I 
performed a Western blot on total worm lysates for wild type and skpo-1 mutants. As shown 
in Figure 3.12, SKPO-1 was detected in wild type, uninfected, animals, but not in the skpo-1 
mutants. I postulate SKPO-1 may be post-translationally modified due to its molecular 
weight (MW) being higher than its predicted a.a. sequence (655)—i.e. 75-100 kDa vs. 73.5 
kDa, respectively. Additionally, there are data that reveal certain animal heme peroxidases 
(hMPO) to be glycosylated, both experimentally and bioinformatically (hMPO; SKPO-1) 
((FURTMULLER et al. 2006), (JOHNSON et al. 1987); data not shown).  
 Finally, to determine if the localization pattern of SKPO-1 was altered during 
infection I exposed L4 worms to either E. coli or E. faecalis for 24 hours, prior to 
immunostaining for SKPO-1. I observed that SKPO-1’s hypodermal localization was 
independent of the host being uninfected or infected (Figure 3.13A-C and 3.13D-F, 
respectively). It is of note that, SKPO-1’s localization to the hypodermis may also explain 
the dumpy phenotype, as mutations in cuticle proteins have been associated with this 
morphological phenotype (PAGE 2007) (Figure 3.8). 
Conclusions and future directions  
SKPO-1 is a functional peroxidase 
In this chapter, I demonstrated that a previously unstudied C. elegans protein with a 
peroxidase domain, F49E12.1, plays a protective role during infection with E. faecalis. I 
named this protein SKPO-1 for ShkT-containing peroxidase, because it contains an N-
terminal ShkT-like domain. The ShkT domain family was originally defined as a potassium 
channel blocker in the sea anemone (Metridium senile). Binding to the potassium channel 
requires two conserved residues that are not found in this particular ShkT-like domain of 
SKPO-1 or others from C. elegans (data not shown). It is postulated that the more general 
function of ShkT-like domains are as contact surfaces for protein interactions (TSANG et al. 
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2007). For this reason, SKPO-1 and other ShkT-containing peroxidases may be most 
closely related to the peroxidasins, subfamily 2 of the peroxidase-cyclooxygenase 
superfamily, and in fact, SKPO-1 was placed in this family by phylogenetic analysis (SOUDI 
et al. 2012). These peroxidase domain-containing proteins also have protein interaction 
domains, but they are typically type C-like immunoglobulin domains, leucine-rich repeats, or 
von Willebrand factor C modules. This is in contrast to the mammalian peroxidases, MPO, 
LPO and EPO that lack these extra domains and belong to subfamily 1 (ZAMOCKY et al. 
2008).  Additionally, it is thought that sub-family 1 evolved from sub-family 2 (ZAMOCKY et 
al. 2008). Other C. elegans peroxidase domain-containing proteins that have a ShkT-like 
domain include MLT-7 (THEIN et al. 2009), C16C8.2 and F32A5.2, but no study has yet 
addressed this domain’s function in the context of a peroxidase. 
 An unexpected finding was that SKPO-1 is located in the hypodermis and is 
functionally protective in this tissue against E. faecalis infection, but not against P. 
aeruginosa which is another well-studied human pathogen in C. elegans. Infection of C. 
elegans with E. faecalis results in colonization of the gut, leading to distension of the 
intestinal lumen and clear signs of physical damage, such as effacement of the microvilli 
(CRUZ et al. 2013), (GARSIN et al. 2001). Though the worm is exposed to E. faecalis on its 
outer surface as it moves through the pathogen lawn, there is no notable colonization or 
characterized physical damage to the cuticle or hypodermis. In contrast, bacterial 
pathogens such as Microbacterium nematophilum, Xenorhabdus nematophila and Yersinia 
pestis adhere to and colonize the cuticle surface (DARBY et al. 2002), (HODGKIN et al. 
2000), (MALLO et al. 2002). The natural fungal pathogen Drechmeria coniospora initially 
adheres to the cuticle and then penetrates the hypodermis whereas the human fungal 
pathogen Candida albicans first colonizes the intestine and eventually penetrates the 
cuticle from the inside out (BREGER et al. 2007), (JANSSON et al. 1985). Our laboratory 
previously showed that tissue-specific loss of bli-3 in the hypodermis also increased 
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susceptibility of C. elegans to E. faecalis (CHAVEZ et al. 2009). Based on the protective 
effects of SKPO-1 and BLI-3 in this tissue, I postulate that a hypodermal immune response 
does play some role in protecting C. elegans during infection with E. faecalis. The question 
is by what mechanism?  
 Several models for how these proteins might exert their protective effects can be 
imagined. It could be that loss of skpo-1 results in a weaker cuticle barrier that increases 
susceptibility. Alternatively, SKPO-1 could use H2O2 produced by BLI-3 to form more potent 
antioxidants, analogous to the human Duox/LPO system on mucosal surfaces (CONNER et 
al. 2002), (FORTEZA et al. 2005), (GEISZT et al. 2003a). Clearly, the amount of H2O2 is 
important. Our laboratory previously showed that loss of BLI-3 and the resulting decrease in 
H2O2 production caused an increase in susceptibility to infection (CHAVEZ et al. 2009), 
whereas in this chapter I show that loss of a peroxidase and a concurrent increase in H2O2 
also increases susceptibility. A similar situation is apparent from studies of infection using 
the model host Drosophila melanogaster (HA et al. 2005a), (HA et al. 2005b). Loss of an 
intestinal DUOX enzyme or an intestinal catalase both increase susceptibility to infection, 
but with opposite effects on ROS levels in this tissue. It is possible that SKPO-1 is 
catalyzing the degradation of excess H2O2 to prevent host damage. Additionally, our 
laboratory demonstrated, by a variety of means, that infection causes oxidative stress in C. 
elegans, much of it dependent on BLI-3 activity (CHAVEZ et al. 2007), (MOHRI-SHIOMI and 
GARSIN 2008), (VAN DER HOEVEN et al. 2011).  
 Interestingly, there is evidence for a hypodermal response to several pathogens that 
are thought to mainly cause infection in the intestine. Microarray studies that examined the 
transcriptional responses of C. elegans to E. faecalis, Serratia marcescens, Erwinia 
carotovora, Photorhabdus luminescens, S. aureus and P. aeruginosa all noted a dramatic 
downregulation in the expression of genes related to cuticle biosynthesis, such as those 
encoding collagens (IRAZOQUI et al. 2010a), (WONG et al. 2007). The response is not 
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thought to be due to a general reduction of gene transcription in this tissue and may be 
indicative of several possibilities (WONG et al. 2007). The changes in transcription of the 
genes could be part of a protective response that is occurring in the hypodermis to protect 
against pathogens. Or the changes could be purposely caused by the pathogens as part of 
their virulence programs to damage the host. Alternatively, the changes in expression of the 
cuticle biosynthetic genes could be a neutral side effect resulting from alterations in 
signaling due to pathogen exposure. Overall, these studies suggest that pathogen 
exposure, even to those pathogens not thought to directly affect the cuticle, cause major 
changes in the expression of the cuticle biosynthetic genes that might be indicative of a 
response to the infection in the hypodermis.  
 In addition to the pathogen susceptibility phenotype, loss of skpo-1 resulted in a 
dumpy phenotype of incomplete penetrance, suggestive of some role in cuticle biosynthesis 
(THEIN et al. 2009). In support of a functional peroxidase domain, I noted that SKPO-1 
shares the same critical residues as MLT-7 in its active site (THEIN et al. 2009), and animals 
mutant for skpo-1 produce significantly more H2O2 during infection. The functional and 
physical location for the protein was shown to be the hypodermis, which was surprising 
since E. faecalis has been characterized as infecting the intestine of C. elegans (CRUZ et al. 
2013), (GARSIN et al. 2001). This result, along with other evidence from the literature 
(IRAZOQUI et al. 2010a), (WONG et al. 2007), suggests that the hypodermis plays an 
important role during exposure of C. elegans to many human pathogens that do not 
obviously colonize or damage the cuticle, warranting further investigation. 
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Chapter 4: Recombinant protein engineering, expression and purification of SKPO-1 
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Introduction 
Recombinant protein engineering, expression, and purification of SKPO-1 
In Chapter 3, I illustrated that live skpo-1 mutants displayed increased H2O2 levels 
relative to wild type animals, when infected, by Amplex Red assay. This assay 
demonstrated that SKPO-1 was a peroxidase in an indirect manner. In order to directly 
determine if SKPO-1 possesses peroxidase activity and is capable of producing 
antimicrobial hypohalous acids to defend the host during infection, I decided to 
recombinantly express and purify SKPO-1. Traditionally, animal heme peroxidase domain-
containing proteins such as MPO, LPO and DUOX are expressed in eukaryotes using a 
baculovirus system (MEITZLER and ORTIZ DE MONTELLANO 2009). Recently it was 
demonstrated that the BLI-3 peroxidase domain and the MLT-7 peroxidase displayed 
peroxidase activity following expression and purification from E. coli (EDENS et al. 2001), 
(THEIN et al. 2009). After conversing with members of the labs that claimed to have utilized 
E. coli to express these eukaryotic peroxidase domains, I decided to express a full-length, 
functional, SKPO-1 protein with a C-terminal HIS6 tag in E. coli BL21 (DE3) (Drs. Lambeth 
and Page, personal communications). If the SKPO-1 protein is insoluble, I could at least 
use it to generate a polyclonal antibody (pAb) and perform immunohistochemistry (IHC) in 
C. elegans. Additionally, if everything failed I would have the opportunity to express skpo-1 
in a eukaryotic system with the help of some potential collaborators.   
Results 
Recombinant protein expression in E. coli  
Outlined below is the protein schema for how I expressed and purified SKPO-
1::HIS6 from E. coli (Figure 4.1). Wild type, full-length, SKPO-1 cDNA was cloned into the 
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pET-29b(+) expression system using standard, molecular techniques and the primers listed 
in Table 2.2. For all pET constructs used in this study, I inoculated 500 mL of fresh LB 
media supplemented with Kanamycin (Kan; 50 ug/mL) with single isolated colonies. These 
cultures were allowed to incubate, shaking, for 15 hours at 37˚ C. 100 mL of each starter 
culture was then transferred to 900 mL of fresh LB Kan (50 ug/mL) and allowed to incubate, 
shaking, for 4 hours at 37˚ C. Thus, 2 liters of each plasmid was grown (uninduced and 
induced conditions). For induction, 1 mM IPTG (final concentration; isopropyl β-D-1-
thiogalactopyranoside) was introduced into the corresponding cultures. All cultures were 
transferred to the 30˚ C shaking incubator and grown for an additional 3 hours prior to 
harvesting, chemical lysis and purification.  
Cells were chemically lysed in B-PER buffer containing 80 ug/mL lysozyme, 
Roche® protease inhibitor cocktail tablet plus 1mM PMSF (phenylmethylsufonyl fluoride) 
and stored on ice when necessary to limit degradation of recombinant full-length SKPO-
1::HIS6. Following ultracentrifugation and membrane pellet solubilization, I ran 5 uL of the 
crude extract, insoluble and soluble fractions for cells expressing SKPO-1::HIS6 pET-
29b(+) and empty vector (uninduced and induced conditions). There was no difference in 
total protein levels between uninduced and induced conditions by Coomassie. Therefore, I 
omitted the uninduced samples from Figure 4.2. By Coomassie, I observed no discernible 
difference in total protein levels between empty vector and SKPO-1::HIS6-expressing pET-
29b(+) in the crude extract, as well as the soluble and insoluble fractions (Figure 4.2). By 
using THE™ His Tag, mouse, monoclonal antibody (mAb) and a goat anti-mouse HRP-
conjugated secondary, I was unable to detect the full-length SKPO-1::HIS6 expression 
product in all fractions (~74 kilodaltons; kDa). However, I detected two degradation 
products of SKPO-1::HIS6 running between ~37-49 kDa in the crude extract and insoluble, 
but not soluble, fraction. 
83 
 
Following further communication with Dr. Page, I decided to only express the 
SKPO-1 peroxidase domain with the C-terminal HIS6 tag. Dr. Page suggested that the 
ShkT-like domain may have impeded proper protein folding of SKPO-1 in E. coli (personal 
communication with Dr. Page). Similar to the full-length SKPO-1::HIS6 construct, I 
observed that the C-terminal HIS6-tagged SKPO-1 peroxidase domain was only detected in 
the crude extract and insoluble fraction (Figures 4.3-4.5). In addition to the previously 
observed degradation products, I observed a novel expression product from cells 
expressing the SKPO-1::HIS6 peroxidase domain as compared to the full-length version. 
The novel product was ~64 kDa which roughly corresponds with the predicted size of the 
SKPO-1::HIS6 peroxidase domain construct (~60 kDa) which possesses ~50 a.a. upstream 
and downstream of the peroxidase domain, but excludes the ShkT-like domain—modeled 
after the MLT-7 construct used by Thein et al. (THEIN et al. 2009).  
I decided that the likelihood of obtaining a functionally active SKPO-1::HIS6 protein 
from E. coli was unlikely, and thus decided to purify the insoluble aggregate in order to have 
a polyclonal antibody raised against the SKPO-1 peroxidase domain. On the off chance that 
the HIS6 tag was solvent exposed, I attempted purification under native conditions as 
opposed to immediately attempting to purify the aggregate under denaturing conditions. 
The latter process would have required denaturation, as well as introducing hemin (heme 
precursor) in resolubilization buffers (ZONG et al. 1995). In order to purify the SKPO-1::HIS6 
peroxidase domain, I used a TALON® purification protocol, a cobalt ion variant of the 
nickel-NTA (nitrilotriacetic acid) resin, and a native buffer combination previously used to 
purify a C. elegans HSP70 chaperone from E. coli (ODUNUGA et al. 2012). By Western blot, 
I observed that the C-terminal HIS6-tagged SKPO-1 peroxidase domain was detected in 
the crude extract pre- and post-TALON® incubation flow through (Figure 4.4). However, the 
SKPO-1::HIS6 peroxidase domain was absent in the subsequent wash and eluate fractions. 
84 
 
Additionally, progressive increases in the imidazole concentration did not result in elution of 
SKPO-1::HIS6 peroxidase domain. These results suggest that the HIS6 tag is not solvent 
exposed and thus cannot bind to the TALON® resin. Thus, the two alternatives were to 
attempt denaturation and resolubilization of the SKPO-1::HIS6 peroxidase domain or to 
clone the SKPO-1 peroxidase domain into the pET-28(a)+ vector, thus moving the position 
of the HIS6 tag to the N-terminus. 
Using different primers (Table 2.2), I cloned the SKPO-1 peroxidase domain into the 
pEt-28a(+) vector to introduce the HIS6 tag at the protein’s N-terminus and expressed the 
construct in E. coli BL21 (DE3) cells. The rationale for moving the position of the HIS6 tag 
was two-fold. While the HIS6 tag is small, it may have lowered the peroxidase domain’s 
solubility at the C-terminus. Additionally, the HIS6 tag may interfere with the peroxidase 
domain’s enzymatic activity, as the peroxidase domain is in the C-terminus of the protein. 
Unfortunately, like the other two attempts, the peroxidase domain was insoluble and 
degraded when expressed in E. coli as evidenced by Figure 4.5. Thus, it does not appear 
that the HIS6 tag’s position is affecting the protein’s stability in E. coli. Additionally, I was 
never able to detect SKPO-1 by Coomassie, only by Western blot, which is problematic for 
having a pAb raised against the insoluble SKPO-1 aggregate; most companies require 5 
mg/mL of purified protein. I could have pursued denaturation and resolubilization of the 
protein or attempted expressing SKPO-1’s peroxidase domain with a GST tag to increase 
solubility. However, I had already established a collaboration with Dr. Leto, who offered to 
express the SKPO-1 peroxidase using his baculovirus system (Dr. Leto, personal 
communication). 
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Figure 4.1 Recombinant SKPO-1 protein expression and purification scheme from E. 
coli BL21 (DE3). The protein expression process was uniform between the three different 
constructs tested minus the SKPO-1 cDNA content and HIS6-tag positioning. Full-length, 
wild type, SKPO-1 cDNA was cloned into the pET-29b(+) vector upstream of the C-terminal 
HIS6 tag. Wild type SKPO-1 peroxidase domain cDNA was cloned into the pET-29b(+) and 
pET-28a(+) vectors such that the HIS6 tag was at the C- or N-terminus of the cDNA, 
respectively. Empty vector pET-29b(+) served as the control in both A and B. Empty vector 
pET-28a(+) served as the control in C. C.E. = crude extract. Blue pellet = E. coli cell pellet 
or lysed cell pellet. 
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Figure 4.2 Full-length SKPO-1::HIS6 protein is degraded and present in the insoluble 
fraction. All lanes are of samples that were induced with 1mM IPTG. By the Coomassie 
brilliant blue (CBB) stained-SDS-PAGE gel, I observed no discernible difference in the 
protein expression level of full-length SKPO-1::HIS6 (C-terminus) in the crude extract, 
soluble or insoluble fractions as compared to the corresponding pET-29b(+) empty vector 
samples. By Western blot, SKPO-1::HIS6 degradation products were detected in the crude 
extract and insoluble fraction, but not the soluble fraction. No full-length SKPO-1::HIS6 was 
detected (unpublished data). 
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Figure 4.3 SKPO-1::HIS6 peroxidase domain pET-29b(+) construct expresses higher 
MW recombinant species. All lanes are of samples that were induced with 1mM IPTG. By 
Coomassie, I was unable to detect a difference in SKPO-1::HIS6 protein levels for the 
recombinant peroxidase domain variant as compared to the empty vector pET-29b(+) crude 
extract. By Western blot, I observed a ~64 kDa MW species was present in E. coli BL21 
(DE3) cells expressing the SKPO-1::HIS6 peroxidase domain construct. This higher MW 
species is absent in the full-length SKPO-1::HIS6 expressing E. coli (unpublished data). 
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Figure 4.4 The C-terminal HIS6-tagged SKPO-1 peroxidase domain is unable to bind 
the TALON resin. A). 5 ul of each sample was loaded into a SDS-PAGE gel, 
electrophoresed and stained with CBB. I observed proteinaceous content in all lanes minus 
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the lanes containing eluates treated with increasing imidazole. B) 5 ul of each sample was 
used in the immunoblot. After 1˚ and 2˚ antibody, and luminol treatment, I observed α-HIS6 
reactive products corresponding to 64 and 29 kDa in the C.E. pre-TALON® incubation flow 
through. The 29 kDa α-HIS6 reactive product is present in the C.E. post-TALON® 
incubation flow through. The resin was then washed three times (W1-3), but the α-HIS6 
reactive product was absent in the flow through. I steadily increased the imidazole 
concentration (200-800 mM) in the elution buffer and collected their corresponding eluate 
fractions, but did not observe any α-HIS6 reactive product B).., This result, in conjunction 
with Figure 4.5, suggests that the HIS6 tag is hidden within the insoluble SKPO-1::HIS6 
protein, and thus unable to bind to the TALON resin (unpublished data). 
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Figure 4.5 HIS6 tag position does not affect the solubility and degradation of the 
recombinant SKPO-1::HIS6 peroxidase domain. Wild type SKPO-1 peroxidase domain 
cDNA was cloned in both pET-29b(+) and pET-28a(+) and expressed in E. coli BL21 (DE3), 
left and right lanes respectively. By Western blot, I observed that the SKPO-1 peroxidase is 
degraded in E. coli. Additionally, the HIS6 tag position did not affect recombinant protein 
expression i.e. more or less SKPO-1::HIS6 recombinant species were not detected due to 
the tag’s position (unpublished data). 
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Conclusions and future directions 
Expression and purification of SKPO-1::HIS6 using E. coli 
While successful expression of peroxidase-domain containing proteins is possible, 
expressing eukaryotic proteins in heterologous eukaryotic systems is the most reliable 
method (for eukaryotic heme peroxidases) ((JOHNSON et al. 1987), (MEITZLER and ORTIZ DE 
MONTELLANO 2009), (MEITZLER et al. 2010), (MEITZLER and ORTIZ DE MONTELLANO 2011), 
(SHIMOKAWA and SMITH 1991)). Unfortunately, while I successfully expressed some 
versions of SKPO-1 in E. coli, they were degraded and insoluble. E. coli is an important 
protein expression system, but it is not always ideal for expressing certain proteins. As E. 
coli protein expression is relatively quick and inexpensive it is a good system for initial 
troubleshooting. As for why skpo-1 expression was unsuccessful in E. coli there are several 
possible reasons. One issue may have been rare codon bias in which skpo-1 is 
improperly/poorly translated as certain tRNAs are rare or lacking in E. coli and can result in 
premature translation termination and/or amino acid misincorporation (DEL TITO et al. 
1995). Disulfide bond formation is another important consideration when expressing 
proteins in E. coli because the cytosol is highly reducing and thus is not a favorable 
environment for disulfide bond formation (PRINZ et al. 1997). The E. coli Rosetta-gamiTM 
2(DE3) strain possesses all seven rare tRNAs on a chloramphenicolr (Cam) plasmid and 
has mutations in glutathione reductase (gor) and thioredoxin reductase (trxB) which 
enhances formation of disulfide bonds in the cytoplasm (DEL TITO et al. 1995), (PRINZ et al. 
1997). I used this strain to express skpo-1 but observed SKPO-1 to be degraded and 
present only in the insoluble fraction similar to the construct expressed in BL21 (DE3). 
Therefore, I doubt rare codon bias or disulfide bond formation were the main problems. An 
additional problem for expressing eukaryotic proteins in E. coli include solubility issues 
which can be remedied by fusing the gene to glutathione-S-transferase (GST) or maltose-
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binding protein (MBP). However, I did not attempt to fuse these tags to skpo-1 as Thein et 
al used a HIS6 tag and claimed to have success (THEIN et al. 2009). Additionally, I had 
already formed a collaboration with Dr. Leto at the NIH to have skpo-1 expressed using his 
baculovirus system (Dr. Leto, personal communication) 
 One final issue concerns the types of posttranslational modifications supported by 
E. coli. E. coli is incapable of catalyzing N- and O-linked glycosylation amongst other 
posttranslational modifications (BRONDYK 2009). N-linked glycosylation can occur at an Asn 
residue within the Asn-Xaa-Ser/Thr triplet motif of the polypeptide in the endoplasmic 
reticulum (ER) (HUTTMANN et al. 2013), (WEERAPANA and IMPERIALI 2006). Loss of N-linked 
glycans has been observed to have variable effects on proteins (HUTTMANN et al. 2013), 
(ZONG et al. 1995). In some cases, N-linked glycosylation is required for enzymatic activity 
of some proteins, and in others cases, loss of glycosylation does not affect enzymatic 
activity. α-amylase and chloroperoxidase (CPO) are respective examples (HUTTMANN et al. 
2013), (ZONG et al. 1995). MPO, LPO, EPO (myeloperoxidase, lactoperoxidase, and 
eosinophil peroxidase, respectively) are examples of N-linked glycosylated proteins. 
Typically, these mammalian heme peroxidases are recombinantly expressed and purified in 
eukaryotic systems such as the baculovirus-Spodoptera frugiperda Sf9 and Sf21 
expression systems (MEITZLER and ORTIZ DE MONTELLANO 2009). However, there are 
examples of peroxidase domain containing proteins being successfully expressed from E. 
coli—CPO, MLT-7 and BLI-3’s peroxidase domain (EDENS et al. 2001), (THEIN et al. 2009), 
(ZONG et al. 1995). CPO, from Caldariomyces fumago, typically possesses N-glycosyl 
moieties; however, the CPO expressed in E. coli lacked these N-linked glycans, yet 
demonstrated wild type-like peroxidase activity (ZONG et al. 1995). Unfortunately, 
recombinantly expressed CPO from E. coli lacked heme and was always present in the 
periplasm as an insoluble protein (ZONG et al. 1995). Thus, Zong et al. had to denature and 
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renature CPO and introduce heme to CPO before the recombinant protein displayed 
peroxidase activity (ZONG et al. 1995). Likewise, Thein et al. had insolubility issues when 
they were expressing the MLT-7 peroxidase domain from E. coli (Dr. Andy Page, personal 
communication). By bioinformatics (www.cbs.dtu.dk/services/NetNGlyc/), MLT-7 has 
predicted N-glycosyl sites; however, this has not been experimentally determined. Edens et 
al. claim to have successfully expressed an active BLI-3 peroxidase domain from E. coli 
(EDENS et al. 2001). This result is contentious within the NOX/DUOX field, as only one lab 
has been able to successfully express a functional NOX/DUOX protein in a prokaryotic 
system. Also, BLI-3 lacks any N-glycosyl sites (EDENS et al. 2001). By bioinformatics, 
SKPO-1 is predicted to possess asparagine-derived glycosylation sites 
(www.cbs.dtu.dk/services/NetNGlyc/).  
With all of these setbacks, I was unable to express enough of the insoluble 
peroxidase domain to have a pAb raised against SKPO-1. On the upside, I gained 
experience with protein expression and purification as well as established a collaboration to 
have SKPO-1 expressed in a eukaryotic system. The ultimate goal of the collaboration 
would involve me directly assessing, by in vitro biochemical assays, SKPO-1’s peroxidase 
and microbicidal activity (HA et al. 2005a), (THEIN et al. 2009). However, while the 
collaboration is ongoing, I have yet to receive the purified protein and I no longer have the 
time to do these assays. With respect to having a pAb raised for IHC, I designed a synthetic 
SKPO-1 peroxidase domain peptide to be chemically synthesized and have a pAb raised in 
rabbits against said peptide by Lifetein®. This endeavor was successful and is covered in 
Chapter 3. 
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Chapter 5: SKPO-1 transgenic nematodes 
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Introduction 
SKPO-1 transgenic nematodes 
While assessing SKPO-1’s peroxidase activity by biochemical assays is important 
for definitively establishing its peroxidase and/or microbicidal abilities, this does not address 
where SKPO-1 is expressed in C. elegans in non-stress and stress conditions. As I had yet 
to have the α-SKPO-1 polyclonal antibody made, I decided to complement my hypodermal 
RNAi findings from Chapter 3 by creating transgenic nematodes to observe SKPO-1 tissue 
localization. By creating skpo-1::GFP constructs and introducing them into wild type C. 
elegans I would be able to visualize SKPO-1::GFP during infected and uninfected 
conditions. Additionally, if this approach worked I would be able to potentially determine 
whether SKPO-1::GFP and BLI-3::mCherry co-localize during infected and uninfected 
conditions by introducing the skpo-1::GFP construct into bli-3::mCherry-expressing C. 
elegans.  
Microinjection of skpo-1::GFP constructs 
One standard method of transgenesis in C. elegans is microinjection. To introduce 
the transgene into C. elegans by microinjection, the DNA is introduced into the cytoplasmic 
syncytium of the gonads by a glass needle (EVANS 2006), (MELLO et al. 1991). The plasmid 
DNA homologously recombines into a large, heritable, extrachromosomal array that is able 
to be integrated into the chromosome upon UV radiation (EVANS 2006), (MELLO et al. 1991). 
Co-injecting the transgene-of-interest along with a phenotypic marker plasmid allows visual 
confirmation of whether the injection was successful (EVANS 2006), (MELLO et al. 1991). 
Under advisement from Dr. Kyung Park, I did not use a co-injection marker because the 
partial skpo-1 ORF was translationally fused to GFP, thus bypassing the need (Figure 5.1A) 
(Dr. Kyung Park, personal communication). After I successfully injected ~30-60 young 
adult, wild type, animals, I allowed them to recover and lay eggs. I screened the 
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subsequent F1 progeny by using a fluorescent dissecting microscope, but did not observe 
any GFP-expressing worms at any developmental stage. I requested aid from my 
microinjection mentor, Dr. Park, to inject the same plasmid just in case my technique was 
poor. Likewise, Dr. Park did not observe GFP-expressing F1 progeny at any developmental 
stage. A potential problem with the first construct may have been that the required 
regulatory information was further upstream of the sequence I used in this translational 
fusion (EVANS 2006). Thus, I increased the length of the upstream regulatory sequence to 
include sequence from the upstream gene, ubc-24 (Figure 5.1B). Again I injected ~30-60 
young adult, wild type, worms and screened the resulting F1 progeny for GFP-expression. 
However, the progeny lacked GFP-expression. Likewise, when Dr. Park injected this 
construct, he did not observe GFP-expression in the F1 progeny. 
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Figure 5.1 skpo-1 sequences for C. elegans transgenesis. skpo-1 sequence used to 
create a translational GFP fusion, in pPD95.75, for microinjection into C. elegans gonads (A 
and B, respectively). In this figure, the intron between exon 1 and 2 in skpo-1 has been 
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excised for simplicity, however, it is present in the actual construct. All annotated features 
within the skpo-1 sequence are hypothetical and based on motifs generally recognized as 
important in eukaryotic transcriptional and translational regulation. The insert in B 
possesses a putative CCAAT enhancer element as well as a second tentative TATA box as 
opposed to the insert in A (unpublished data). 
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Conclusions and future directions 
The lack of GFP-expressing progeny suggests that the amount of regulatory 
sequence supplied with the skpo-1 insert was inadequate for driving expression of GFP. It 
has also been observed that certain transgenes are toxic to the embryo (EVANS 2006), 
(MELLO et al. 1991). Thus, no progeny would have been observed. I designed the 
constructs to include the 5’ transcriptional and translational elements deigned necessary for 
proper expression (EVANS 2006). Additionally, I included the first two exons as well as the 
first intron as pre-mRNA splicing is important for stability as well as translation (EVANS 
2006). It has been demonstrated that synthetic introns also increase reporter gene 
expression and the GFP within pPD95.75 contains synthetic introns (EVANS 2006). The 
pPD95.75 lacks the heterologous 3’ unc-54 UTR that is present in some, but not all, Andy 
Fire vectors. These vectors are typically used for microinjection and/or gene bombardment 
in C. elegans. While the 3’ UTR is important in translation, I decided against including the 
native 3’ UTR in the constructs I used as many successful transgenic constructs are 
designed without it, as mentioned above ((AN and BLACKWELL 2003); Drs. Van der Hoeven 
and Park, personal communications). Unfortunately, I recently learned that 3’ UTRs in C. 
elegans are very important for successful expression and proper localization of the 
expressed gene product (Drs Arur and Vizuete; personal communications). Therefore, I 
postulate the lack of further exons, introns and/or the lack of the 3’UTR may explain why 
expression of these skpo-1::GFP constructs was unsuccessful. Another consideration is 
that the GFP fused to the partial SKPO-1 protein may have been misfolded due to improper 
subcellular targeting. Therefore, the GFP would not fluoresce as the product was degraded. 
Both constructs possessed the first two exons of skpo-1 fused to gfp. This could have been 
problematic as the ShkT-like domain is encoded within the second exon 
(www.WormBase.org). In C. elegans, the ShkT-like domain is purported to support protein-
protein interactions; however, this has not been experimentally determined yet (TSANG et al. 
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2007). It is possible that the ShkT-like domain is not targeted to the proper subcellular 
areas which could result in the fusion product being degraded.  
While these constructs were unsuccessful, I have one last alternative for successful 
transgenesis. I received a cosmid from the Max Planck Institute (MPI) that contains a large 
portion of chromosome II (~45 kilobases) and all of the skpo-1 ORF. Thus, this cosmid 
could be introduced into C. elegans through microinjection or gene bombardment to create 
a transgenic worm. As this cosmid contains all of the upstream and downstream regulatory 
information of skpo-1 there is a higher chance of proper expression. Additionally, within the 
skpo-1 ORF is a gfp ORF near the 3’-end of the skpo-1 ORF, thus it is possible to visually 
observe expression of skpo-1. If this approach were successful, I would suggest introducing 
the skpo-1 containing cosmid into the BLI-3::mCherry-expressing C. elegans strain. This 
BLI-3::mCherry is a translational fusion that was constructed by Dr. van der Hoeven and the 
strain was created by Dr. Park. As all attempts at determining co-localization of SKPO-1 
and BLI-3 in C. elegans by immunohistochemistry (IHC) have been unsuccessful, this 
method may prove otherwise. 
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Chapter 6: Final Conclusions and Perspectives 
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SKPO-1 localizes and contributes to the host’s immune response in the hypodermis  
 In this body of work, I determined by RNAi the involvement of three previously 
unknown peroxidase genes in the host immune response—F09F3.5, R08F11.7, and 
F49E12.1. F49E12.1 was characterized in detail and observed to belong to the short 
peroxidasin family (SOUDI et al. 2012). However, due to the presence of a metridin ShkT-
like domain at its N-terminus, in addition to its C-terminal peroxidase domain, I renamed 
F49E12.1 to skpo-1 (ShkT-containing peroxidase). In Chapter 3, I determined that SKPO-1 
is involved in the host immune response during infection with E. faecalis, but not P. 
aeruginosa. Additionally, I observed by immunohistochemistry SKPO-1 localizes to the 
hypodermis, where BLI-3 has been demonstrated to localize and supply H2O2 to MLT-7 for 
cuticle biogenesis (EDENS et al. 2001), (THEIN et al. 2009) (Figure 6.1). SKPO-1 contributes 
to the innate immune response at the hypodermal, not the intestinal, interface which was 
very surprising. This finding is interesting as a majority of host-pathogenesis studies in C. 
elegans focus on the intestinal immune response. As C. elegans is a bacteriovore, the 
intestinal tract comes into contact with the ingested microbes that have either been lysed 
due to pharyngeal grinding or those microbes that are still intact. The bacteria that avoid 
being lysed by the pharyngeal grinder are able to colonize the intestine, which is the case 
for human pathogens P. aeruginosa, S. aureus, and E. faecalis (IRAZOQUI et al. 2010a), 
(VAN DER HOEVEN et al. 2011). Published data thus far suggest P. aeruginosa, S. aureus, 
and E. faecalis cause disease within the C. elegans intestine (IRAZOQUI et al. 2010a), (VAN 
DER HOEVEN et al. 2011). The hypodermal-specific skpo-1 RNAi data implicate E. faecalis 
kills C. elegans by causing an infection at the hypodermis presumably by damaging the 
cuticle. It has been demonstrated that P. aeruginosa, S. aureus, and E. faecalis 
downregulate the expression of genes involved in cuticle biosynthesis which could indicate 
these pathogens are hampering the host’s ability to repair the damaged cuticle (IRAZOQUI et 
al. 2010a), (WONG et al. 2007). E. faecalis is hampering the host’s ability to repair the 
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damaged cuticle by downregulating expression of cuticle biosynthesis genes. Thus, it is 
possible that E. faecalis causes unappreciated pathology to the hypodermis of the worms 
that does not occur during P. aeruginosa infection.  
Other pathogens are well recognized for causing hypodermal pathology. For 
example, D. coniospora infects C. elegans by attaching to the cuticle and then penetrating 
the cuticle as well as the underlying hypodermis (PUJOL et al. 2008). Hyphae used in the 
colonization of C. elegans then develop from the appressorial structures used to puncture 
the cuticle and hypodermis (PUJOL et al. 2008). In C. elegans it was genetically determined 
that expression of the antimicrobial neuropeptide-like peptide (NLP), nlp-29, is upregulated 
in response to infection through (Toll/IL-1R) TIR-1-p38 MAPK signaling (PUJOL et al. 2008). 
However, through sterile wounding, i.e. wounding of the hypodermis in the absence of 
bacteria or fungi, it was determined that nlp-29 expression is controlled by a different 
kinase, NIPI-3 (no induction of peptide after Drechmeria infection), upstream of the p38 
MAPK cascade (PUJOL et al. 2008). Pujol et al. observed a thick layer of cuticle had been 
secreted forming a scar where he wound occurred in the C. elegans cuticle (PUJOL et al. 
2008). As the C. elegans p38 MAPK ortholog, PMK-1, is extremely important in both 
hypodermal and intestinal immune/stress responses it comes as little surprise to see its 
involvement. Thus, C. elegans is able to differentiate between disparate stimuli whose 
upstream signals converge into the major immune response cascade. 
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Figure 6.1 Model for BLI-3/SKPO-1 hypodermal localization. BLI-3 localizes to the 
apical membrane of the hypodermal cell where it supplies H2O2 to extracellular peroxidases 
for the purpose of immune defense. SKPO-1 is predicted to be a secreted, extracellular 
peroxidase that localizes to the apical surface of the hypodermis beneath the cuticle 
(extracellular matrix). Listed are three possibilities (1, 2, and 3) for SKPO-1’s localization. 
1). SKPO-1 is not physically associated with the hypodermal cell surface but is in close 
proximity to BLI-3. 2). In order to efficiently use BLI-3-produced H2O2 during an immune 
response, SKPO-1 physically interacts with BLI-3, perhaps by forming a hetero-dimer with 
the peroxidase-like domain. 3). Like in scenario 1, SKPO-1 is in close proximity to BLI-3 in 
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order to use its H2O2; however, SKPO-1 physically interacts with the apical membrane of 
the hypodermal cell surface or with an unknown protein. The orange waves represent the 
cross-linked cuticle. 
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As to why there was no significant difference in the susceptibility of wild type and 
skpo-1 animals to P. aeruginosa, I hypothesize that P. aeruginosa utilizes its heme-
scavenging proteins to subvert the BLI-3/SKPO-1 oxidative defense system. I only exposed 
wild type and skpo-1 worms to the “slow killing” mode of action, wherein P. aeruginosa 
colonizes the worm, as opposed to the “fast killing” mode of action which involves toxin 
production. The reason I tested the slow killing phenotype is that it is easier to discover 
pathogen susceptibility phenotypes as the worms die over a period of 2-3 days versus fast 
killing, in which a LT50 is obtained by 10 hours (RUIZ-DIEZ et al. 2003). I hypothesize there 
are enough similarities between the slow killing and fast killing phenotypes that it is likely 
that P. aeruginosa would also nullify SKPO-1’s ability to defend the host in the presence of 
the phenazine pyocyanin (RUIZ-DIEZ et al. 2003), (TAN et al. 1999a), (TAN et al. 1999b). The 
main difference between these modes of killing is the production, or lack of, phenazine 
toxins such as pyocyanin (fast vs slow killing, respectively).  
In C. elegans, pyocyanin is necessary for fast killing (MAHAJAN-MIKLOS et al. 1999). 
Pyocyanin is able to traverse plasma membranes due to its zwitterionic nature and exerts 
its toxicity by redox cycling (RADA et al. 2008). Through its redox cycling nature, pyocyanin 
promotes ROS production within host cells leading to oxidative damage to the host (RADA 
et al. 2008). One method of potentiating oxidative damage to the host is by oxidizing 
glutathione (GSH) to GSSG (oxidized GSH) thereby depleting the pool of an available 
antioxidant (RADA et al. 2008). In combination with this method, pyocyanin also utilizes the 
available NADPH within the host cells resulting in O2.- and H2O2 molecules that damage the 
host (RADA et al. 2008). As observed in mammals, this subterfuge of consuming the host’s 
available NADPH prevents the host from mounting an effective oxidative burst (RADA et al. 
2008). Like all NOX/DUOX systems, the DUOX1/2-LPO-SCN- antimicrobial system requires 
107 
 
NADPH to provide the electrons to the NOX domain of the DUOX proteins to ultimately 
produce H2O2 to aid in clearance of P. aeruginosa in the airway (RADA et al. 2008).  
It is possible that in C. elegans, pyocyanin is able to counteract the BLI-3/SKPO-1 
defense system by consuming the host’s NADPH, O2, as well as oxidize GSH and generate 
unwanted ROS-mediated oxidative damage. Additionally, the pyocyanin may interfere with 
BLI-3 trafficking and/or protein folding by preventing incorporation of the heme groups 
within BLI-3’s NOX domain. I propose that pyocyanin interferes with heme incorporation 
and thus BLI-3-produced H2O2 being supplied to SKPO-1 when P. aeruginosa hemophores 
are present. An alternative hypothesis is that SKPO-1 is not involved in the host immune 
response during P. aeruginosa infection. P. aeruginosa has been characterized through 
electron and light microscopy to strictly colonize and affect pathology within the intestinal 
tract of C. elegans (IRAZOQUI et al. 2010a). As I did not use P. aeruginosa to screen the 
putative peroxidase genes, (Table 3.1) it is possible that another peroxidase may contribute 
to the intestinal immune response during P. aeruginosa infection. Therefore, SKPO-1 may 
be the main peroxidase responsible for the hypodermal immune response during E. faecalis 
infection, but one or more peroxidases may contribute to an intestinal immune response 
during P. aeruginosa infection. P. aeruginosa may also possess other ROS-detoxification 
mechanisms that protect it from the hypodermal immune response that involves SKPO-1.  
My data preliminarily suggest that SKPO-1 contributes to the immune response by 
its peroxidase activity and this protective activity is dependent on BLI-3-produced H2O2. 
While SKPO-1 displays peroxidase activity, I have yet to determine how SKPO-1 is utilizing 
its peroxidase activity to aid the host during E. faecalis infection i.e. in a microbicidal, wound 
repair or antioxidant capacity. Whatever ROS-consuming function(s) SKPO-1 serves in 
hypodermal immunity, it is likely to be essential in defending against other cuticle damaging 
pathogens like D. coniospora as it enters C. elegans by puncturing the cuticle and 
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hypodermis. Thus, it is likely that the skpo-1 mutant may display enhanced susceptibility to 
D. coniospora. It is also likely that a bli-3 mutant would have a similar susceptibility 
phenotype as BLI-3 supplies ROS to SKPO-1 during infection. 
With respect to NOX-derived ROS-mediated innate immune signaling, Matsuzawa 
and Park et al. elegantly demonstrated that host mammalian cells produced ROS upon 
detection of LPS by TLR4 (MATSUZAWA et al. 2005), (PARK et al. 2004). As the HEK293T 
(HEK293 expressing SV40 large T-antigen) cells lack the NOX2 multiprotein complex 
present in neutrophils and macrophages, yet produce ROS in response to LPS, it must be 
due to a different NOX isoform (PARK et al. 2004). While HEK293 cells normally express 
NOX4, these cells do not express TLR4 endogenously and thus must be transfected in 
order to express TLR4 (PARK et al. 2004). By exposing HEK293T cells to LPS, Park et al. 
observed a significant increase in H2O2 as determined by NF-κB-dependent luciferase 
reporter activity (PARK et al. 2004). However, upon introduction of diphenyleneiodinium 
chloride (DPI) to these LPS-stimulated cells, a drastic reduction in luciferase activity was 
observed (PARK et al. 2004). A similar reduction in LPS-induced ROS-stimulated 
fluorescence was observed by Matsuzawa et al. when mice RAW264.7 cells pre-treated 
with HPF (hydroxyphenyl fluorescein) were incubated with either antioxidant propyl gallate 
or N-acetyl-L-cysteine (PG and NAC, respectively) (MATSUZAWA et al. 2005). Both of these 
cell-based assays suggest the involvement of NOX4 producing ROS in response to TLR4-
mediated detection of LPS. Park et al. demonstrated direct binding of NOX4 and TLR4 in 
response to LPS treatment by co-IP (co-immunoprecipitation) and Y2H (yeast two-hybrid) 
(PARK et al. 2004). This PAMP-induced binding event is exciting as it demonstrates a 
PAMP-binding receptor directly interacting with a ROS-producing enzyme whose ROS 
ultimately mediates pro-inflammatory cytokine production (IL-6, IL-1β, and TNF; tumor 
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necrosis factor) through the mammalian p38 MAPK signaling cascade (MATSUZAWA et al. 
2005), (PARK et al. 2004). 
In C. elegans, the PAMP and/or DAMP receptor proteins are unknown. Thus, how 
these important primary signaling molecules are detected, and their information transmitted 
in the form of secondary messengers to the host cells is unknown. An interesting 
hypothesis put forth by van der Hoeven et al., is that BLI-3, through its C-terminus, may 
directly interact with the unknown receptor involved in detection of PAMPs and/or DAMPs 
resulting in ROS production, much like NOX4 (VAN DER HOEVEN et al. 2011). Thus, in 
response to E. faecalis infection, BLI-3 increases H2O2 production and SKPO-1 contributes 
to the hypodermal immune response by using its peroxidase activity to potentially aid in 
wound repair, hypohalous acid production and/or ROS detoxification (Figure 6.2). 
A previously unconsidered role for SKPO-1 is detoxification of ROS by acting as a 
pseudocatalase (DAS et al. 1995), (JANTSCHKO et al. 2005). It was previously observed in 
the rat stomach that GPO (gastric peroxidase) possessed pseudocatalase activity in the 
presence of SCN- (DAS et al. 1995). In the rat stomach, the oxidized product OSCN- cannot 
accumulate due to the high concentration of GSH, which in turn, is oxidized to GSSG (DAS 
et al. 1995). The GSSG is then reduced back to GSH by GR (glutathione reductase) and 
NADPH. Due to the hexose monophosphate shunt pathway, NADPH is produced and 
serves as an electron donor for GR (DAS et al. 1995). This is important because GPO can 
reduce H2O2 to H2O and O2 in the presence of SCN- and GSH can reduce OSCN- (a potent 
oxidant) back to SCN- (DAS et al. 1995). However, to accomplish this, GSSG needs to be 
reduced by GR to GSH, which requires NADPH (DAS et al. 1995). Similar pseudocatalase 
activity has been observed with LPO, MPO, and TPO (thyroid peroxidase) in the presence 
of high H2O2 concentrations (DAS et al. 1995), (JANTSCHKO et al. 2005). Thus, SKPO-1 in 
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response to pathogen-induced oxidative stress may aid in ameliorating H2O2 levels in C. 
elegans hypodermal cells. 
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Figure 6.2 Putative roles of SKPO-1 in response to E. faecalis infection. SKPO-1 
utilizes BLI-3-produced H2O2 in response to E. faecalis infection at the hypodermal surface. 
It is possible that SKPO-1 contributes to the hypodermal immune response by producing a 
hypohalous acid to kill E. faecalis. Another role could involve SKPO-1 repairing the worm’s 
cuticle. Finally, SKPO-1 may act as pseudocatalase and prevent BLI-3-mediated oxidative 
damage to the host due to H2O2 accumulation. It is conceivable that SKPO-1 may 
contribute to the hypodermal immune response by fulfilling one or more of the listed 
possibilities. It is currently unclear how SKPO-1 utilizes BLI-3-produced H2O2; however, 
both proteins are required for SKPO-1 to contribute to the host’s immune response to E. 
faecalis. XOH = unknown hypohalous acid. 
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Expanding our understanding of SKPO-1 
 While the body of work presented here has led to one role for SKPO-1 in C. 
elegans, there are other avenues that need to be explored, especially as it is the first heme 
peroxidase involved with the C. elegans immune response. While my efforts to assess 
whether SKPO-1 and BLI-3 co-localize have been unsuccessful, there are alternatives. As 
mentioned in Chapter 5, the skpo-1::GFP containing cosmid from the Max Planck Institute 
could be introduced into C. elegans by gene bombardment into the pBLI-3::mCherry-
expressing C. elegans strain. By creating this strain, “real-time” in vivo imaging could be 
obtained with respect to how, or if, BLI-3 and SKPO-1 functionally interact during different 
stresses—such as infection with various pathogenic microorganisms. An additional benefit 
to introducing the skpo-1::GFP cosmid into C. elegans would be being able to observe 
skpo-1 expression during the worm’s development, especially with respect to cuticle 
biogenesis during the different larval stages.   
Previously, I attempted to determine if BLI-3 and SKPO-1 co-localize in the 
hypodermis by immunofluorescence, but I was unsuccessful. Additionally, my attempt at co-
localization of SKPO-1 and BLI-3 using the pBLI-3::mCherry-expressing strain failed, I 
hypothesize this may have been due to the mCherry fluorophore being inactivated due to 
fixation, which was necessary for exposing the hypodermis by freeze-crack 
immunohistochemistry (IHC). However, there are two other approaches to assess if these 
proteins co-localize. One approach is to perform immuno-gold electron microscopy in which 
secondary antibodies, specific to each protein, labeled with different sized gold-particles are 
used. The other approach is co-immunoprecipitation (co-IP) using whole worm lysates. 
Additionally, co-IP would determine if these proteins physically interact or merely coexist 
together in the hypodermis. If BLI-3 and SKPO-1 physically interact the next step would be 
to generate a SKPO-1 protein, which lacks the ShkT domain, as it is purported to be a 
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general protein interaction domain in C. elegans (TSANG et al. 2007). Additionally, it was 
demonstrated that the hDUOX1 peroxidase-like domain mediates protein-protein 
interactions by its solvent-exposed cysteines and this function may be conserved in BLI-3 
(MEITZLER et al. 2013). A potential problem with the co-IP approach is that BLI-3 is an 
integral membrane protein, thus this approach may not be feasible.  
Determining why disruption of SKPO-1 results in ~50% of the worms to display a 
dpy phenotype of incomplete penetrance is also an interesting question. The collagen 
protein DPY-7 is involved in maintaining wild type-like annular furrow rings in the cuticle 
(THEIN et al. 2009). Misprocessing of collagen proteins by disrupting the enzymes, like 
MLT-7, that act on collagen proteins often result in a dpy phenotype (THEIN et al. 2009). 
When these rings were disrupted in the mlt-7 mutant, they observed that the normally 
circumferential annular rings displayed a mycelia-like pattern in the dpy worms (THEIN et al. 
2009). By using an anti-DPY-7 collagen antibody in conjunction with an Alexa Fluor 488 
secondary antibody, as Thein et al. did in their work on MLT-7, I would be able to determine 
if SKPO-1 is involved in cross-linking the cuticle similar to MLT-7 and BLI-3 (THEIN et al. 
2009)... Another experiment would be to assess the degree of tyrosine cross-linked COL-
12::Ty and DPY-13::Ty (collagen 12 and dumpy 13, tyrosine epitope-tagged proteins) by 
Western Blot (THEIN et al. 2009). This method was used by Thein et al. to determine that 
both MLT-7 and BLI-3, individually, affected assembly of these two collagens, both of which 
are important in cuticle biogenesis (THEIN et al. 2009). One other interesting experiment to 
conduct using skpo-1 worms is cuticle permeability. Thein et al. demonstrated that in mlt-7 
worms, the cuticle was more permeable to the nuclei marker Hoescht 33258 (THEIN et al. 
2009). This assay demonstrated that the cuticle of wild type animals excluded the Hoescht 
stain, while the cuticle of the mlt-7 worms was unable to preclude nuclear staining (THEIN et 
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al. 2009). By performing this assay, I would be able to quickly assess SKPO-1’s role in 
cuticle cross-linking versus the more biochemical methods proposed.  
In Chapter 3, by IHC in uninfected and infected conditions, I did not observe an 
increase in SKPO-1 at the hypodermis. Therefore, it is possible that SKPO-1’s peroxidase 
activity increases in response to E. faecalis infection similar to BLI-3-mediated H2O2 
production. In order to directly determine if SKPO-1 possesses peroxidase and/or 
microbicidal activity, I would need to purify SKPO-1. My attempts at expression and 
purification of SKPO-1 from E. coli were unsuccessful. The possible reasons for this could 
be rare codon bias, improper glycosylation, improper disulfide bond formation as well as 
missing a necessary protein-protein interaction. However, the collaboration underway 
involves expression of full-length skpo-1 cDNA in a baculovirus system by a protein-
expression core facility at the NIH. Upon receiving purified SKPO-1, I would be able to 
biochemically assess the aforementioned properties. A standard in vitro peroxidase activity 
assay involves incubating the purified peroxidase with the tyrosine substrate L-tyrosine 
ethyl ester, or ABTS (2, 2'-Azino-di(3-ethylbenzthiazoline-6-sulfonate)), as mentioned in 
Chapter 1. In a seminal paper by Ha et al., they determined microbicidal activity of the 
Drosophila DUOX peroxidase homology domain (PHD) by incubating the purified PHD with 
NaCl, H2O2 and Erwinia carotovora Ecc15 (HA et al. 2005a). They allowed the pathogen to 
incubate with this mixture and then performed a colony-forming unit (CFU) assay and 
observed that there was a significant decrease in CFUs when the three constituents were 
present (HA et al. 2005a). I would test different (pseudo)halides (Br-, Cl-, and SCN-) with 
purified SKPO-1 in conjunction with E. faecalis, D. coniospora, and P. aeruginosa followed 
by a CFU assay to observe if SKPO-1 is capable of producing hypohalous antimicrobial 
oxidants. By performing these assays, the C. elegans field would potentially learn if C. 
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elegans possesses an oxidative burst defense mechanism similar to those present in 
vertebrates. 
As mentioned in Chapter 1, ROS such as H2O2 are important in modulating the host 
innate immune response by triggering the hypersensitive response in plants or by 
promoting chemotaxis of leukocytes to sites of injury in Danio rerio (DESIKAN et al. 2000), 
(LEVINE et al. 1996), (NIETHAMMER et al. 2009). Other ROS such as HOCl and OSCN- are 
potent antimicrobial agents produced in response to pathogens at different locations within 
cells and tissues (CONNER et al. 2002), (KLEBANOFF et al. 2013). These oxidative burst 
defense mechanisms are important as a first line of defense against pathogens as defects 
in producing the potent antimicrobial oxidants can result in serious infections—chronic 
granulomatous disease (CGD) and cystic fibrosis (CF) (COHEN et al. 1981), (MOSKWA et al. 
2007).Thus, if BLI-3 and SKPO-1 cooperated together similar to mammalian oxidative 
defense systems it would be an exciting discovery as it would further elucidate the innate 
immune response in C. elegans. Additionally, it would demonstrate that the antimicrobial 
oxidative defense system is evolutionarily conserved from C. elegans to humans. 
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